1
|
Xu LL, Cheng TC, Xiang NJ, Chen P, Jiang ZW, Liu XX. Risk factors for severe low anterior resection syndrome in patients with rectal cancer undergoing sphincter‑preserving resection: A systematic review and meta‑analysis. Oncol Lett 2024; 27:30. [PMID: 38108080 PMCID: PMC10722524 DOI: 10.3892/ol.2023.14163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Accepted: 09/04/2023] [Indexed: 12/19/2023] Open
Abstract
The present study aimed to evaluate the incidence and risk factors of severe low anterior resection syndrome (LARS) in patients with rectal cancer undergoing sphincter-preserving resection, and to provide the clinical basis and reference for the treatment of rectal cancer and the prevention of LARS. Studies on the incidence and risk factors for severe LARS in patients with rectal cancer undergoing sphincter-preserving resection were searched using PubMed, Embase, Cochrane Library, Scopus and Web of Science, according to the inclusion and exclusion criteria. After evaluating the study quality and extracting relevant data, RevMan 5.2 and STATA software were used to conduct a meta-analysis. A total of 12 articles were considered eligible for the present meta-analysis. Within these articles, there were 3,877 cases of sphincter-preserving resection for rectal cancer and 1,589 cases of severe LARS; the incidence of severe LARS was 40.99%. The results of the meta-analysis revealed that sex [female; odds ratio (OR), 6.54; 95% CI, 3.63-11.76; Z, 6.27; P<0.00001], radiotherapy and chemotherapy (OR, 3.45; 95% CI, 2.29-5.21; Z, 5.91; P<0.00001), total mesorectal excision (TME; OR, 4.39; 95% CI, 3.32-5.79; Z, 10.41; P<0.00001), and distance between tumor and anal margin (OR, 2.74; 95% CI, 0.86-8.72; Z, 1.70; P<0.00001) may be the risk factors for severe LARS.
Collapse
Affiliation(s)
- Lu-Lu Xu
- The First Clinical Medical College, Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China
| | - Tian-Cheng Cheng
- The First Clinical Medical College, Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China
| | - Neng-Jun Xiang
- The First Clinical Medical College, Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China
| | - Peng Chen
- The First Clinical Medical College, Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China
| | - Zhi-Wei Jiang
- Department of General Surgery, Jiangsu Provincial Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China
| | - Xin-Xin Liu
- Department of General Surgery, Jiangsu Provincial Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China
| |
Collapse
|
2
|
Xu LL, Xiang NJ, Cheng TC, Li YX, Chen P, Jiang ZW, Liu XX. Application of electroacupuncture in the prevention of low anterior resection syndrome after rectal cancer surgery. World J Gastrointest Surg 2023; 15:2765-2773. [PMID: 38221997 PMCID: PMC10784840 DOI: 10.4240/wjgs.v15.i12.2765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Revised: 11/10/2023] [Accepted: 11/24/2023] [Indexed: 12/27/2023] Open
Abstract
BACKGROUND Low anterior resection syndrome (LARS) is one of the common postoperative complications in patients with rectal cancer, which seriously affects their postoperative recovery and quality of life (QoL). Electroacupuncture therapy is one of the characteristic therapies of traditional Chinese medicine. There are few reports on the prevention and treatment of LARS by electroacupuncture therapy. AIM To explore the clinical effectiveness of electroacupuncture in managing rectal cancer patients with postoperative LARS. METHODS A total of 50 patients with LARS after rectal cancer surgery were retrospectively selected as the research subjects. According to the treatment methods, they were divided into an observation group (n = 25) and a control group (n = 25). During the four-week treatment period, the control group received standard defecation function training, while the observation group received electroacupuncture care and traditional defecation function training. The anal pressure index (which includes anal resting pressure, anal systolic pressure, and maximum tolerable volume), European Organization of Research and Treatment of Cancer (EORTC) QoL C30 (QLQ-C30) score, LARS Scale (LARSS) score, Wexner anal incontinence scale score, Xu Zhongfa five-item 10-point scale score, and the occurrence of adverse reactions were compared between the two groups before and after treatment. RESULTS The experimental group showed considerably enhanced LARSS scores compared to those in the control group after four weeks of treatment. In the first week, second week, and fourth week, the LARSS score and Wexner anal incontinence scale score decreased, and the Xu Zhong method five-item 10-point scale score increased, with significant differences (P < 0.05). The experimental group showed substantial improvements in anal resting pressure, anal systolic pressure, and maximum tolerance volume after undergoing 4 wk of therapy in the untreated group (P < 0.05). The experimental group's QLQ-C30 score on the EORTC QoL questionnaire was higher than that of the control group during the 1st, 2nd, and 4th wk (P < 0.05). No significant variation between the groups in the frequency of adverse reactions (P > 0.05) was observed. CONCLUSION Electroacupuncture positively impacted LARS following rectal cancer surgery, effectively improving clinical symptoms and anal pressure indicators and patients' standard of life.
Collapse
Affiliation(s)
- Lu-Lu Xu
- The First Clinical Medical College, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, Jiangsu Province, China
| | - Neng-Jun Xiang
- The First Clinical Medical College, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, Jiangsu Province, China
| | - Tian-Cheng Cheng
- The First Clinical Medical College, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, Jiangsu Province, China
| | - Yi-Xian Li
- The First Clinical Medical College, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, Jiangsu Province, China
| | - Peng Chen
- The First Clinical Medical College, Nanjing University of Traditional Chinese Medicine, Nanjing 210023, Jiangsu Province, China
| | - Zhi-Wei Jiang
- Department of General Surger, Jiangsu Provincial Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing 210029, Jiangsu Province, China
| | - Xin-Xin Liu
- Department of General Surger, Jiangsu Provincial Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Traditional Chinese Medicine, Nanjing 210029, Jiangsu Province, China
| |
Collapse
|
3
|
Cao CW, Li TT, Pan KS, Jiang ZW, Mo NF, Pang Q, Huang L, Xu ML, Wu YD, Liu GQ. [From treatment to whole course management: envisioning comprehensive management of Talaromycosis marneffei]. Zhonghua Liu Xing Bing Xue Za Zhi 2023; 44:1993-1998. [PMID: 38129159 DOI: 10.3760/cma.j.cn112338-20230627-00399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 12/23/2023]
Abstract
Talaromycosis marneffei has been increasing in recent years. Our understanding of this disease has gradually deepened through extensive basic and clinical research, but there are still many limitations. In this article, by incorporating the latest research advancements, we discuss important issues in managing Talaromycosis marneffei trends, aiming to guide effective prevention and control of the disease, improving public health, and reducing the healthcare burden.
Collapse
Affiliation(s)
- C W Cao
- Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China Guangxi Key Laboratory of Mycoses Prevention and Treatment, Nanning 530000, China Guangxi Zhuang Autonomous Region Health Commission Key Laboratory of Fungi and Mycoses Research and Prevention, Nanning 530000, China
| | - T T Li
- Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China Guangxi Key Laboratory of Mycoses Prevention and Treatment, Nanning 530000, China Guangxi Zhuang Autonomous Region Health Commission Key Laboratory of Fungi and Mycoses Research and Prevention, Nanning 530000, China
| | - K S Pan
- Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China Guangxi Key Laboratory of Mycoses Prevention and Treatment, Nanning 530000, China Guangxi Zhuang Autonomous Region Health Commission Key Laboratory of Fungi and Mycoses Research and Prevention, Nanning 530000, China
| | - Z W Jiang
- Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China Guangxi Key Laboratory of Mycoses Prevention and Treatment, Nanning 530000, China Guangxi Zhuang Autonomous Region Health Commission Key Laboratory of Fungi and Mycoses Research and Prevention, Nanning 530000, China
| | - N F Mo
- Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China Guangxi Key Laboratory of Mycoses Prevention and Treatment, Nanning 530000, China Guangxi Zhuang Autonomous Region Health Commission Key Laboratory of Fungi and Mycoses Research and Prevention, Nanning 530000, China
| | - Q Pang
- Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China Guangxi Key Laboratory of Mycoses Prevention and Treatment, Nanning 530000, China Guangxi Zhuang Autonomous Region Health Commission Key Laboratory of Fungi and Mycoses Research and Prevention, Nanning 530000, China
| | - L Huang
- Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China Guangxi Key Laboratory of Mycoses Prevention and Treatment, Nanning 530000, China Guangxi Zhuang Autonomous Region Health Commission Key Laboratory of Fungi and Mycoses Research and Prevention, Nanning 530000, China
| | - M L Xu
- Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China Guangxi Key Laboratory of Mycoses Prevention and Treatment, Nanning 530000, China Guangxi Zhuang Autonomous Region Health Commission Key Laboratory of Fungi and Mycoses Research and Prevention, Nanning 530000, China
| | - Y D Wu
- Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China Guangxi Key Laboratory of Mycoses Prevention and Treatment, Nanning 530000, China Guangxi Zhuang Autonomous Region Health Commission Key Laboratory of Fungi and Mycoses Research and Prevention, Nanning 530000, China
| | - G Q Liu
- Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China Guangxi Key Laboratory of Mycoses Prevention and Treatment, Nanning 530000, China Guangxi Zhuang Autonomous Region Health Commission Key Laboratory of Fungi and Mycoses Research and Prevention, Nanning 530000, China
| |
Collapse
|
4
|
Sun H, Jiang H, Jiang ZW, Fang G, Dai ZX, Wang Z, Sun X, Wang W. Analysis of risk factors for surgical site infection after colorectal surgery: a cross-sectional study in the east of China pre-COVID-19. Front Public Health 2023; 11:1204337. [PMID: 37637824 PMCID: PMC10457116 DOI: 10.3389/fpubh.2023.1204337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2023] [Accepted: 07/31/2023] [Indexed: 08/29/2023] Open
Abstract
Background The occurrence of surgical site infection (SSI) can prolong the postoperative hospital stay, increase the economic burden of patients, and even endanger their lives. The purpose of this study was to investigate the incidence, risk factors, and microbiology of SSI after colorectal surgery (CRS) and to provide a basis for the prevention and control of SSI. Methods A single-center, prospective, cross-sectional study of adult patients undergoing CRS was conducted from 2010-2019. Univariate and multivariate logistic regression models were used to collect and analyze demographic information, hospital characteristics, and potential perioperative risk factors of SSI. Results A total of 3,302 eligible patients were included in this study, with 213 cases experiencing SSIs, resulting in an infection rate of 6.45%. Notably, the incidence of SSI decreased from 13.33% in 2010 to 3.56% in 2019 (Ptrend < 0.001). Escherichia coli accounted for the majority of isolated microorganisms (37.09%), with 49 strains exhibiting resistance to one or more antibiotics (35.25%). Multivariate analysis showed that diabetes, anastomosis leakage, wound classification (contaminated/dirty), operation duration, blood loss greater than 200 ml, and NNIS risk index score for 2 or 3 were independent risk factors. Conversely, laparoscopic approach, preoperative bowel preparation and preoperative albumin levels emerged as protective factors against SSI after CRS. Furthermore, compared to non-SSI patients, SSI patients had a significantly higher 30-day mortality rate following surgery (0.23% vs. 2.35%, p < 0.05). Conclusion SSI after CRS was susceptible to many factors, and the pathogen of SSI was mainly Escherichia coli. In clinical practice, measures such as correcting preoperative hypoproteinemia, choosing laparoscopic surgery, preoperative bowel preparation and shortening the duration of surgery should be taken to reduce the incidence of SSI.
Collapse
Affiliation(s)
- Hui Sun
- Medical Department, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China
| | - Hua Jiang
- Medical Department, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China
| | - Zhi-Wei Jiang
- Medical Department, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China
| | - Ge Fang
- Medical Department, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China
| | - Zheng-Xiang Dai
- Infection Management Department, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China
| | - Zhiguo Wang
- Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Xiang Sun
- Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province, China
| | - Wen Wang
- Department of Rheumatology and Immunology, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian, Jiangsu Province, China
| |
Collapse
|
5
|
Feng GW, Wang ZF, He P, Lan QY, Ni L, Yang YZ, Wang CF, Cui TT, Huang LL, Yan YQ, Jiang ZW, Yang Q, Yu BW, Han X, Chen JJ, Yang SY, Yuan L, Zhou LY, Liu G, Li K, Huang Z, Zhao JC, Hu ZY, Xie ZQ. Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trial. Hum Vaccin Immunother 2023; 19:2262635. [PMID: 37881130 PMCID: PMC10644802 DOI: 10.1080/21645515.2023.2262635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Accepted: 09/20/2023] [Indexed: 10/27/2023] Open
Abstract
This was a phase 1 dose-escalation study of ZR202-CoV, a recombinant protein vaccine candidate containing a pre-fusion format of the spike (S)-protein (S-trimer) combined with the dual-adjuvant system of Alum/CpG. A total of 230 participants were screened and 72 healthy adults aged 18-59 years were enrolled and randomized to receive two doses at a 28-day interval of three different ZR202-CoV formulations or normal saline. We assessed the safety for 28 days after each vaccination and collected blood samples for immunogenicity evaluation. All formulations of ZR202-CoV were well-tolerated, with no observed solicited adverse events ≥ Grade 3 within 7 days after vaccination. No unsolicited adverse events ≥ Grade 3, or serious adverse events related to vaccination occurred as determined by the investigator. After the first dose, detectable immune responses were observed in all subjects. All subjects that received ZR202-CoV seroconverted at 14 days after the second dose by S-binding IgG antibody, pseudovirus and live-virus based neutralizing antibody assays. S-binding response (GMCs: 2708.7 ~ 4050.0 BAU/mL) and neutralizing activity by pseudovirus (GMCs: 363.1 ~ 627.0 IU/mL) and live virus SARS-CoV-2 (GMT: 101.7 ~ 175.0) peaked at 14 days after the second dose of ZR202-CoV. The magnitudes of immune responses compared favorably with COVID-19 vaccines with reported protective efficacy.
Collapse
Affiliation(s)
- Guang-Wei Feng
- Vaccine Clinical Research Center, Henan Provincial Center for Disease Control and Prevention, Zhenzhou, HA, China
| | - Zhong-Fang Wang
- State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, GD, China
- Division of Drug and Vaccine Research, Guangzhou Laboratory, Bioland, Guangzhou, GD, China
| | - Peng He
- Department of Hepatitis and Enterovirus Vaccine, National Institutes for Food and Drug Control, Beijing, China
| | - Qin-Ying Lan
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Ling Ni
- School of Medicine, Tsinghua University, Beijing, China
| | - Ya-Zheng Yang
- School of Medicine, Tsinghua University, Beijing, China
| | - Chen-Fei Wang
- Department of Hepatitis and Enterovirus Vaccine, National Institutes for Food and Drug Control, Beijing, China
| | - Ting-Ting Cui
- State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, GD, China
| | - Li-Li Huang
- Vaccine Clinical Research Center, Henan Provincial Center for Disease Control and Prevention, Zhenzhou, HA, China
| | - Yong-Qiang Yan
- Vaccine Program Office, Xiangcheng County Center for Disease Control and Prevention, Xiangcheng, HA, China
| | - Zhi-Wei Jiang
- Statistics and Decision Sicence, Beijing Key Tech Statistical Consulting Co. Ltd, Beijing, China
| | - Qing Yang
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Bang-Wei Yu
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Xi Han
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Jing-Jing Chen
- R&D Department, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, China
| | - Shu-Yuan Yang
- R&D Department, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, China
| | - Lin Yuan
- R&D Department, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, China
| | - Ling-Yun Zhou
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Ge Liu
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Ke Li
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Zhen Huang
- R&D Department, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, China
| | - Jin-Cun Zhao
- State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, GD, China
- Division of Drug and Vaccine Research, Guangzhou Laboratory, Bioland, Guangzhou, GD, China
| | - Zhong-Yu Hu
- Department of Hepatitis and Enterovirus Vaccine, National Institutes for Food and Drug Control, Beijing, China
| | - Zhi-Qiang Xie
- Vaccine Clinical Research Center, Henan Provincial Center for Disease Control and Prevention, Zhenzhou, HA, China
| |
Collapse
|
6
|
Wang LW, Chen P, Liu J, Jiang ZW, Liu XX. Small bowel diverticulum with enterolith causing intestinal obstruction: A case report. World J Gastrointest Surg 2023; 15:1256-1261. [PMID: 37405091 PMCID: PMC10315109 DOI: 10.4240/wjgs.v15.i6.1256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Revised: 04/04/2023] [Accepted: 04/20/2023] [Indexed: 06/15/2023] Open
Abstract
BACKGROUND Small bowel diverticula are rare in clinics, and small intestinal obstruction caused by coprolites is rarer and difficult to diagnose early. The true incidence of these diverticula may be underestimated due to their clinical symptoms not differing from those of small bowel obstruction resulting from other causes. It is common in the elderly, although it can occur at any age.
CASE SUMMARY This is a case report of a 78-year-old man with epigastric pain for 5 d. Conservative treatment does not effectively relieve pain, inflammatory indicators are elevated, and computed tomography suggests jejunal intussusception and mild ischemic changes in the intestinal wall. Laparoscopic exploration showed that the left upper abdominal loop was slightly edematous, the jejunum mass at the near Flex ligament was palpable, the size was about 7 cm × 8 cm, the local movement was slight, and the diverticulum was seen 10 cm downward, and the local small intestine was dilated and edema. Segmentectomy was performed. After the short parenteral nutrition after surgery, the fluid and enteral nutrition solution were pumped through the jejunostomy tube, and the patient was discharged after the treatment was stable, and the jejunostomy tube was removed in an outpatient clinic one month after the operation. Postoperative pathology: Jejunectomy specimen: (1) Small intestinal diverticulum with chronic inflammation, ulcer with full-thickness activity, and necrosis of the intestinal wall in some areas; (2) also see that the hard object is consistent with stone changes; and (3) the incision margin on both sides shows chronic inflammation of mucosal tissue.
CONCLUSION Clinically, the diagnosis of small bowel diverticulum is difficult to distinguish from jejunal intussusception. Combined with the patient’s condition, rule out other possibilities after a timely disease diagnosis. According to the patient’s body tolerance adopt personalized surgical methods to achieve better recovery after surgery.
Collapse
Affiliation(s)
- Li-Wen Wang
- Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210000, Jiangsu Province, China
| | - Peng Chen
- Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210000, Jiangsu Province, China
| | - Jiang Liu
- Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210000, Jiangsu Province, China
| | - Zhi-Wei Jiang
- Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210000, Jiangsu Province, China
| | - Xin-Xin Liu
- Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210000, Jiangsu Province, China
| |
Collapse
|
7
|
Shi LW, Li J, Yu BW, Huang LR, Li K, Ji M, Zhou LY, Yuan L, Yang SY, Chen JJ, Wang L, Jiang ZW, Li RC, Li YP, Xia JL, Mo ZJ, Li CG. Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females. Hum Vaccin Immunother 2023:2209001. [PMID: 37249310 DOI: 10.1080/21645515.2023.2209001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023] Open
Abstract
As global supply is still inadequate to address the worldwide requirements for HPV vaccines, we assessed the safety and immunogenicity of a new bivalent HPV16/18 vaccine. In this randomized, double-blind, placebo-controlled, phase 2 trial, healthy 9-45-year-old Chinese females in three age cohorts (600 aged 9-17 years; 240 aged 18-26 years; 360 aged 27-45 years) were randomized 1:1 to receive three doses (0,2,6 months) of HPV16/18 vaccine or placebo. We measured neutralizing antibodies against HPV 16 and 18 at 7 months and monitored safety to 12 months in all age cohorts; 9-17-year-old girls were monitored for safety and immunogenicity to 48 months. In vaccinees, 99.8% seroconverted for HPV 16 and 18 types at 7 months; respective GMTs of 5827 (95% CI: 5249, 6468) and 4223 (3785, 4713) were significantly (p < .001) higher than controls for all comparisons. GMTs in the 9-17-year-olds, which were significantly higher than in older women at 7 months, gradually declined to 48 months but remained higher than placebo with seropositivity rates maintained at 98.5% and 97.6% against HPV 16 and 18, respectively. Adverse events occurred at similar rates after vaccine and placebo (69.8% vs. 72.5%, p = .308), including solicited local reactions and systemic adverse events which were mainly mild-to-moderate. The bivalent HPV16/18 vaccine was well tolerated and induced high levels of neutralizing antibodies in all age groups which persisted at high levels to 48 months in the 9-17-year-old age group which would be the target for HPV vaccination campaigns.
Collapse
Affiliation(s)
- Li-Wei Shi
- Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China
| | - Juan Li
- Division of Respiratory Virus Vaccines, National Institute for Food and Drug Control, Beijing, China
| | - Bang-Wei Yu
- Department of Regulatory and Medical Affairs, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Li-Rong Huang
- Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China
| | - Ke Li
- Department of Regulatory and Medical Affairs, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Min Ji
- Department of Regulatory and Medical Affairs, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Ling-Yun Zhou
- Quality Research Department, Shanghai Zerun Biotechnology Co., Ltd, Shanghai, China
| | - Lin Yuan
- Department of Regulatory and Medical Affairs, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, China
| | - Shu-Yuan Yang
- Department of Regulatory and Medical Affairs, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, China
| | - Jing-Jing Chen
- Department of Regulatory and Medical Affairs, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, China
| | - Ling Wang
- Department of Health Statistics, Air Force Military Medical University, Xi'an, Shanxi, China
| | - Zhi-Wei Jiang
- Department of Health Statistics, Beijing Key Tech Statistical Technology Co. Ltd, Beijing, China
| | - Rong-Cheng Li
- Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China
| | - Yan-Ping Li
- Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China
| | - Jie-Lai Xia
- Department of Health Statistics, Air Force Military Medical University, Xi'an, Shanxi, China
| | - Zhao-Jun Mo
- Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China
| | - Chang-Gui Li
- Division of Respiratory Virus Vaccines, National Institute for Food and Drug Control, Beijing, China
| |
Collapse
|
8
|
Li J, Shi LW, Yu BW, Huang LR, Zhou LY, Shi L, Jiang ZW, Xia JL, Wang XY, Li RC, Yuan L, Li YP, Li CG. Safety and immunogenicity of a pichia pastoris-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine in healthy Chinese women aged 9-45 years: A randomized, double-blind, placebo-controlled phase 1 clinical trial. Vaccine 2023; 41:3141-3149. [PMID: 37061370 DOI: 10.1016/j.vaccine.2023.04.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Revised: 03/28/2023] [Accepted: 04/03/2023] [Indexed: 04/17/2023]
Abstract
BACKGROUND We evaluated the safety and immunogenicity of high and low doses of a novel pichia pastoris-expressed bivalent (types 16 and 18) human papillomavirus (HPV) virus-like particle vaccine. METHODS In this randomized, double-blind, placebo-controlled phase 1 trial, we enrolled 160 healthy females aged 9-45 years in Guangxi, China who were randomized (1:1:2) to receive either low (0.5 mL) or high (1.0 mL) dosages of bivalent HPV vaccine, or placebo (aluminum adjuvant) in a 0, 2, 6 months schedule. Adverse events and other significant conditions that occurred within 30 days after each vaccination were recorded throughout the trial. Sera were collected at days 0, 60, 180 and 210 to measure anti-HPV 16/18 neutralizing antibodies. RESULTS A total of 160 participants received at least one dose of the HPV vaccine and 152 completed the three dose vaccination series. Reporting rates of adverse events in placebo, low dose (0.5 mL) and high dose (1.0 mL) groups were 47.5 %, 55.0 % and 55.0 %, respectively. No serious adverse events occurred during this trial. 100 % of the participants who received three doses of the HPV vaccine produced neutralizing antibodies against HPV 16/18 vaccine. For HPV 16 and HPV 18, the geometric mean titers (GMTs) were similar between the low dose group (GMTHPV 16 = 10816 [95 % CI: 7824-14953]), GMTHPV 18 = 3966 [95 % CI: 2693-5841]) and high dose group (GMT HPV 16 = 14482 [95 % CI: 10848-19333], GMT HPV 18 = 3428 [95 % CI: 2533-4639]). CONCLUSION The pichia pastoris-expressed bivalent HPV vaccine was safe and immunogenic in Chinese females aged 9-45 years. The low dosage (0.5 mL) was selected for further immunogenicity and efficacy study.
Collapse
Affiliation(s)
- Juan Li
- National Institute for Food and Drug Control, Beijing, China
| | - Li-Wei Shi
- Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China
| | - Bang-Wei Yu
- Shanghai Zerun Biotechnology Co., Ltd, Shanghai, China
| | - Li-Rong Huang
- Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China
| | - Ling-Yun Zhou
- Shanghai Zerun Biotechnology Co., Ltd, Shanghai, China
| | - Li Shi
- Shanghai Zerun Biotechnology Co., Ltd, Shanghai, China
| | - Zhi-Wei Jiang
- Department of Health Statistics, Faculty of Preventative Medicine, The Fourth Military Medical University, Xi' an, Shanxi, China
| | - Jie-Lai Xia
- Department of Health Statistics, Faculty of Preventative Medicine, The Fourth Military Medical University, Xi' an, Shanxi, China
| | - Xuan-Yi Wang
- Shanghai Medical College, Fudan University, Shanghai, China
| | - Rong-Cheng Li
- Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China
| | - Lin Yuan
- Walvax Biotechnology Co., Ltd, Kunming, Yunnan, China.
| | - Yan-Ping Li
- Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China.
| | - Chang-Gui Li
- National Institute for Food and Drug Control, Beijing, China.
| |
Collapse
|
9
|
Yang GY, Yuan CY, Tao RY, Xia RC, Wang YL, Dong XY, Chai SY, Wu LM, Jiang ZW, Jiang TT, Chen KQ, Li CT, Chen LQ. Application of SifaInDel 45plex System in the Han and Mongolian Populations. Fa Yi Xue Za Zhi 2022; 38:733-738. [PMID: 36914389 DOI: 10.12116/j.issn.1004-5619.2022.520801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 03/16/2023]
Abstract
OBJECTIVES To investigate the genetic polymorphism of InDel loci in SifalnDel 45plex system in the Han population in Jiangsu Province and the Mongolian population in Inner Mongolia, and to evaluate the effectiveness of the system in forensic medicine. METHODS SifaInDel 45plex system was used for genotyping in blood samples of 398 unrelated individuals from the above two populations, and allele frequencies and population genetic parameters of the two populations were calculated respectively. Eight intercontinental populations in the gnomAD database were used as reference populations. The genetic distances between the two studied populations and eight reference populations were calculated based on the allele frequencies of 27 autosomal-InDels (A-InDels). The phylogenetic trees and multidimensional scaling (MDS) analysis diagrams were constructed accordingly. RESULTS Among two studied populations, the 27 A-InDels and 16 X-InDels showed no linkage disequilibrium between each other and the allele frequency distributions were in Hardy-Weinberg equilibrium. The CDP of the 27 A-InDels in two studied populations were all higher than 0.999 999 999 9, and the CPEtrio were all less than 0.999 9. The CDP of the 16 X-InDels in Han in Jiangsu and Mongolian in Inner Mongolia female and male samples were 0.999 997 962, 0.999 998 389, and 0.999 818 940, 0.999 856 063, respectively. The CMECtrio were all less than 0.999 9. The results of population genetics showed that the Jiangsu Han nationality, Inner Mongolia Mongolian nationality and East Asian population clustered into one branch, showing closer genetic relationship. The other 7 intercontinental populations clustered into another group. And the above 3 populations displayed distant genetic relationships with the other 7 intercontinental populations. CONCLUSIONS The InDels in the SifaInDel 45plex system have good genetic polymorphism in the two studied populations, which can be used for forensic individual identification or as an effective complement for paternity identification, and to distinguish different intercontinental populations.
Collapse
Affiliation(s)
- Guang-Yuan Yang
- Department of Forensic Medicine, Inner Mongolia Medical University, Hohhot 010030, China.,Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China
| | - Chun-Yan Yuan
- Department of Forensic Medicine, Inner Mongolia Medical University, Hohhot 010030, China.,Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China
| | - Rui-Yang Tao
- Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China
| | - Ruo-Cheng Xia
- Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China
| | - Ya-Li Wang
- Department of Forensic Medicine, Inner Mongolia Medical University, Hohhot 010030, China
| | - Xin-Yu Dong
- Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China.,School of Forensic Medicine, Shanxi Medical University, Taiyuan 030001, China
| | - Si-Yu Chai
- Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China.,School of Preclinical Medicine of Zunyi Medical University, Zunyi 563000, Guizhou Province, China
| | - Li-Ming Wu
- Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China.,School of Forensic Medicine, Shanxi Medical University, Taiyuan 030001, China
| | - Zhi-Wei Jiang
- Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China.,Department of Forensic Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, China
| | - Ting-Ting Jiang
- Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China.,School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China
| | - Kai-Qin Chen
- Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China.,School of Preclinical Medicine of Zunyi Medical University, Zunyi 563000, Guizhou Province, China
| | - Cheng-Tao Li
- Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China
| | - Li-Qin Chen
- Department of Forensic Medicine, Inner Mongolia Medical University, Hohhot 010030, China
| |
Collapse
|
10
|
Cheng W, Jiang ZW. [Digitalization of perioperative traumatic stress in enhanced recovery after surgery program: current application and future prospect]. Zhonghua Wei Chang Wai Ke Za Zhi 2022; 25:575-581. [PMID: 35844119 DOI: 10.3760/cma.j.cn441530-20220324-00115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Perioperative traumatic stress is a systemic nonspecific response caused by stimuli such as anesthesia, surgery, pain and anxiety, which lasts throughout the perioperative period.The continuous excessive stress response is not conducive to the postoperative rehabilitation of patients. Enhanced recovery after surgery (ERAS), a research hotspot of modern surgery, can significantly reduce perioperative pain and stress, thus promoting the rehabilitation of patients. With the progress of artificial intelligence and information technology, wearable, non-invasive, real-time heart rate variability (HRV) dynamic monitoring can effectively realize the digitalization of stress monitoring with low price, which is worthy of clinical application. Therefore, the use of HRV for digital monitoring of perioperative stress has a significant research value. Moreover, the combination of HRV and ERAS has shown its advantages and the prospect of clinical application is worthy of anticipating.
Collapse
Affiliation(s)
- W Cheng
- Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210029, China
| | - Z W Jiang
- Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210029, China
| |
Collapse
|
11
|
Jiang ZW, Xia JL. [The discussion of related issues in the efficacy evaluation of COVID-19 vaccine]. Zhonghua Yu Fang Yi Xue Za Zhi 2022; 56:82-86. [PMID: 35092996 DOI: 10.3760/cma.j.cn112150-20210205-00131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
The COVID-19 swept across the countries and regions all over the world in the past one year. The marketing of an effective and safe COVID-19 vaccine is expected to control the spread of the disease. A placebo-controlled field efficacy trial is generally considered in the pivotal study of COVID-19 vaccine to observe whether it is able to reduce the incidence rate of the disease effectively. This paper is to introduce and discuss the considerations in study design and the choice of endpoint, statistical evaluation methods, primary estimand choosing and the strategies to various intercurrent events in the COVID-19 efficacy trials.
Collapse
Affiliation(s)
- Z W Jiang
- Beijing KeyTech Statistical Consulting Co., Ltd, Beijing 100023, China
| | - J L Xia
- Department of Health Statistics, Air Force Military Medical University, Xi'an 710032, China
| |
Collapse
|
12
|
Li Y, Jiang ZW, Liu XX, Pan HF, Gong GW, Zhang C, Li ZR. Avoidance of urinary drainage during perioperative period of open elective colonic resection within enhanced recovery after surgery programme. Gastroenterol Rep (Oxf) 2021; 9:589-594. [PMID: 34925856 PMCID: PMC8677522 DOI: 10.1093/gastro/goab006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/16/2019] [Revised: 06/20/2020] [Accepted: 07/22/2020] [Indexed: 12/04/2022] Open
Abstract
Background Urinary catheterization (UC) is a conventional perioperative measure for major abdominal operation. Optimization of perioperative catheter management is an essential component of the enhanced recovery after surgery (ERAS) programme. We aimed to investigate the risk factors of urinary retention (UR) after open colonic resection within the ERAS protocol and to assess the feasibility of avoiding urinary drainage during the perioperative period. Methods A total of 110 colonic-cancer patients undergoing open elective colonic resection between July 2014 and May 2018 were enrolled in this study. All patients were treated within our ERAS protocol during the perioperative period. Data on patients’ demographics, clinicopathologic characteristics, and perioperative outcomes were collected and analysed retrospectively. Results Sixty-eight patients (61.8%) underwent surgery without any perioperative UC. Thirty patients (27.3%) received indwelling UC during the surgical procedure. Twelve (10.9%) cases developed UR after surgery necessitating UC. Although patients with intraoperative UC had a lower incidence of post-operative UR [0% (0/30) vs 15% (12/80), P = 0.034], intraoperative UC was not testified as an independent protective factor in multivariate logistic analysis. The history of prostatic diseases and the body mass index were strongly associated with post-operative UR. Six patients were diagnosed with post-operative urinary-tract infection, among whom two had intraoperative UC and four were complicated with post-operative UR requiring UC. Conclusion Avoidance of urinary drainage for open elective colonic resection is feasible with the implementation of the ERAS programme as the required precondition. Obesity and a history of prostatic diseases are significant predictors of post-operative UR.
Collapse
Affiliation(s)
- Yun Li
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P.R. China.,Jiangxi Institute of Digestive surgery, Nanchang, Jiangxi 330006, P.R. China
| | - Zhi-Wei Jiang
- Department of General Surgery, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, P.R. China
| | - Xin-Xin Liu
- Department of General Surgery, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, P.R. China
| | - Hua-Feng Pan
- Department of General Surgery, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, P.R. China
| | - Guan-Wen Gong
- Department of General Surgery, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, P.R. China
| | - Cheng Zhang
- Department of General Surgery, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, P.R. China
| | - Zheng-Rong Li
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P.R. China.,Jiangxi Institute of Digestive surgery, Nanchang, Jiangxi 330006, P.R. China
| |
Collapse
|
13
|
Yao B, Gui T, Zeng X, Deng Y, Wang Z, Wang Y, Yang D, Li Q, Xu P, Hu R, Li X, Chen B, Wang J, Zen K, Li H, Davis MJ, Herold MJ, Pan HF, Jiang ZW, Huang DCS, Liu M, Ju J, Zhao Q. Correction to: PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling. Genome Med 2021; 13:154. [PMID: 34607606 PMCID: PMC8491380 DOI: 10.1186/s13073-021-00966-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Affiliation(s)
- Bing Yao
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China.,Department of Medical Genetics, Nanjing Medical University, Nanjing, China
| | - Tao Gui
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Xiangwei Zeng
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Yexuan Deng
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Zhi Wang
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Ying Wang
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Dongjun Yang
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Qixiang Li
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Peipei Xu
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Ruifeng Hu
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Xinyu Li
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Bing Chen
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Jin Wang
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Ke Zen
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Haitao Li
- Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Tsinghua-Peking Joint Center for Life Sciences, School of Medicine, Tsinghua University, Beijing, China
| | - Melissa J Davis
- The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia
| | - Marco J Herold
- The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia
| | - Hua-Feng Pan
- Department of General Surgery, the Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China
| | - Zhi-Wei Jiang
- Department of General Surgery, the Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China
| | - David C S Huang
- The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia
| | - Ming Liu
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China.
| | - Junyi Ju
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China.
| | - Quan Zhao
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China.
| |
Collapse
|
14
|
Zhang H, Wen XD, Ma X, Zhu YQ, Jiang ZW, Huang SQ, Wang T, Liu WH. Triple guidance of choledochoscopy, ultrasonography, and computed tomography facilitates percutaneous catheter drainage of infected walled-off necrosis. Insights Imaging 2021; 12:137. [PMID: 34580791 PMCID: PMC8476709 DOI: 10.1186/s13244-021-01087-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2021] [Accepted: 08/12/2021] [Indexed: 11/12/2022] Open
Abstract
Objectives Percutaneous catheter drainage (PCD) is usually performed to treat acute pancreatitis complicated by infected walled-off necrosis (WON). Insufficient drainage of infected WON may lead to a prolonged recovery process. Here, we introduce a modified PCD strategy that uses the triple guidance of choledochoscopy, ultrasonography, and computed tomography (CUC-PCD) to improve the therapeutic efficiency. Methods This study retrospectively analysed 73 patients with acute pancreatitis-related WON from January 2015 to January 2021. The first 38 patients were treated by ultrasonography/computed tomography-guided PCD (UC-PCD), and the next consecutive 35 patients by CUC-PCD. Perioperative data, procedural technical information, treatment outcomes, and follow-up data were collected. Results Demographic characteristics were statistically comparable between the two treatment groups (p > 0.05). After 48 h of PCD treatment, the CUC-PCD group achieved a significantly smaller size of the infected WON (p = 0.023), lower inflammatory response indexes (p = 0.020 for white blood cells, and p = 0.031 for C-reactive protein), and severity scores than the UC-PCD group (p < 0.05). Less catheter duration (p = 0.001), hospitalisation duration (p = 0.000), and global costs (p = 0.000) were observed in the CUC-PCD group compared to the UC-PCD group. There were no differences between the two groups regarding the rate of complications. Conclusions CUC-PCD is a safe and efficient approach with potential clinical applicability for treating infected WON owing to its feasibility in placing the drainage catheter at the optimal location in real time and performing primary necrosectomy without sinus tract formation and enlargement.
Collapse
Affiliation(s)
- Hui Zhang
- General Surgery Center, The General Hospital of Western Theater Command (Chengdu Military General Hospital), Chengdu, 610083, Sichuan Province, China
| | - Xu-Dong Wen
- Department of Gastroenterology and Hepatology, Chengdu First People's Hospital, Chengdu, 610016, Sichuan Province, China
| | - Xiao Ma
- General Surgery Center, The General Hospital of Western Theater Command (Chengdu Military General Hospital), Chengdu, 610083, Sichuan Province, China
| | - Yong-Qiang Zhu
- General Surgery Center, The General Hospital of Western Theater Command (Chengdu Military General Hospital), Chengdu, 610083, Sichuan Province, China
| | - Zhi-Wei Jiang
- General Surgery Center, The General Hospital of Western Theater Command (Chengdu Military General Hospital), Chengdu, 610083, Sichuan Province, China
| | - Shang-Qing Huang
- General Surgery Center, The General Hospital of Western Theater Command (Chengdu Military General Hospital), Chengdu, 610083, Sichuan Province, China
| | - Tao Wang
- General Surgery Center, The General Hospital of Western Theater Command (Chengdu Military General Hospital), Chengdu, 610083, Sichuan Province, China.
| | - Wei-Hui Liu
- Department of Gastroenterology and Hepatology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, Sichuan Province, China.
| |
Collapse
|
15
|
Yao B, Gui T, Zeng X, Deng Y, Wang Z, Wang Y, Yang D, Li Q, Xu P, Hu R, Li X, Chen B, Wang J, Zen K, Li H, Davis MJ, Herold MJ, Pan HF, Jiang ZW, Huang DCS, Liu M, Ju J, Zhao Q. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling. Genome Med 2021; 13:58. [PMID: 33853662 PMCID: PMC8048298 DOI: 10.1186/s13073-021-00871-5] [Citation(s) in RCA: 51] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Accepted: 03/17/2021] [Indexed: 01/12/2023] Open
Abstract
BACKGROUND Aberrant changes in epigenetic mechanisms such as histone modifications play an important role in cancer progression. PRMT1 which triggers asymmetric dimethylation of histone H4 on arginine 3 (H4R3me2a) is upregulated in human colorectal cancer (CRC) and is essential for cell proliferation. However, how this dysregulated modification might contribute to malignant transitions of CRC remains poorly understood. METHODS In this study, we integrated biochemical assays including protein interaction studies and chromatin immunoprecipitation (ChIP), cellular analysis including cell viability, proliferation, colony formation, and migration assays, clinical sample analysis, microarray experiments, and ChIP-Seq data to investigate the potential genomic recognition pattern of H4R3me2s in CRC cells and its effect on CRC progression. RESULTS We show that PRMT1 and SMARCA4, an ATPase subunit of the SWI/SNF chromatin remodeling complex, act cooperatively to promote colorectal cancer (CRC) progression. We find that SMARCA4 is a novel effector molecule of PRMT1-mediated H4R3me2a. Mechanistically, we show that H4R3me2a directly recruited SMARCA4 to promote the proliferative, colony-formative, and migratory abilities of CRC cells by enhancing EGFR signaling. We found that EGFR and TNS4 were major direct downstream transcriptional targets of PRMT1 and SMARCA4 in colon cells, and acted in a PRMT1 methyltransferase activity-dependent manner to promote CRC cell proliferation. In vivo, knockdown or inhibition of PRMT1 profoundly attenuated the growth of CRC cells in the C57BL/6 J-ApcMin/+ CRC mice model. Importantly, elevated expression of PRMT1 or SMARCA4 in CRC patients were positively correlated with expression of EGFR and TNS4, and CRC patients had shorter overall survival. These findings reveal a critical interplay between epigenetic and transcriptional control during CRC progression, suggesting that SMARCA4 is a novel key epigenetic modulator of CRC. Our findings thus highlight PRMT1/SMARCA4 inhibition as a potential therapeutic intervention strategy for CRC. CONCLUSION PRMT1-mediated H4R3me2a recruits SMARCA4, which promotes colorectal cancer progression by enhancing EGFR signaling.
Collapse
Affiliation(s)
- Bing Yao
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China.,Department of Medical Genetics, Nanjing Medical University, Nanjing, China
| | - Tao Gui
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Xiangwei Zeng
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Yexuan Deng
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Zhi Wang
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Ying Wang
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Dongjun Yang
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Qixiang Li
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Peipei Xu
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Ruifeng Hu
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Xinyu Li
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Bing Chen
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Jin Wang
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Ke Zen
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China
| | - Haitao Li
- Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Tsinghua-Peking Joint Center for Life Sciences, School of Medicine, Tsinghua University, Beijing, China
| | - Melissa J Davis
- The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia
| | - Marco J Herold
- The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia
| | - Hua-Feng Pan
- Department of General Surgery, the Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China
| | - Zhi-Wei Jiang
- Department of General Surgery, the Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China
| | - David C S Huang
- The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia
| | - Ming Liu
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China.
| | - Junyi Ju
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China.
| | - Quan Zhao
- The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China.
| |
Collapse
|
16
|
Zhou X, Zhang XA, Jiang ZW, Yang X, Zhang XL, Yang Q. Combined characterization of a new member of Marivita cryptomonadis strain LZ-15-2 isolated from cultivable phycosphere microbiota of highly toxic HAB dinoflagellate Alexandrium catenella LZT09. Braz J Microbiol 2021; 52:739-748. [PMID: 33742357 DOI: 10.1007/s42770-021-00463-w] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2020] [Accepted: 02/23/2021] [Indexed: 12/18/2022] Open
Abstract
During our conveying the microbial structures of phycosphere microbiota (PM) derived from diverse marine harmful algal bloom (HAB) dinoflagellates, a new rod-sharped, white-colored cultivable bacterial strain, designated as LZ-15-2, was isolated from the PM of highly toxic Alexandrium catenella LZT09. Phylogenetic analysis of 16S rRNA gene sequence indicated that strain LZ-15-2 belonged to the genus Marivita within the family Rhodobacteraceae, and demonstrated the highest gene similarity of 99.2% to M. cryptomonadis CL-SK44T, and less than 98.65% with other type strains of Marivita. Phylogenomic calculations on average nucleotide identity (ANI) and digital DNA-DNA hybridization (dDDH) values between the new isolate and M. cryptomonadis CL-SK44T were 99.86% and 99.88%, respectively. Genomic comparison of strain LZ-15-2 with available genomes of Marivita species further verified its taxonomic position within the genus of Marivita. Moreover, comparative genomics analysis showed a proximal similarity of strain LZ-15-2 with M. cryptomonadis CL-SK44T, and it also revealed an open pan-genome status based on constructed gene accumulation curves among Marivita members with 9,361 and 1,712 genes for the pan- and core-genome analysis, respectively. Based on combined polyphasic taxonomic characteristics, strain LZ-15-2 represents a new member of M. cryptomonadis, and proposed as a potential candidate for further exploration of the detailed mechanisms governing the dynamic cross-kingdom algae-bacteria interactions (ABI) between PM and their algal host LZT09.
Collapse
Affiliation(s)
- Xin Zhou
- ABI Group of GPM Project, Department of Marine Chemistry, College of Marine Science and Technology, Zhejiang Ocean University, Zhoushan, 316022, China
| | - Xiao-Ai Zhang
- Guangdong Key Laboratory for Crop Germplasm Resources Preservation and Utilization, Agro-Biological Gene Research Center, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China
| | - Zhi-Wei Jiang
- Institute of Animal Science, Key Laboratory of Animal Nutrition and Feed Science in South China, Ministry of Agriculture and Rural Affairs, State Key Laboratory of Livestock and Poultry Breeding, Guangdong Provincial Key Laboratory of Animal Breeding and Nutrition, Maoming Branch, Guangdong Laboratory for Lingnan Modern Agriculture, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China
| | - Xi Yang
- Institute of Animal Science, Key Laboratory of Animal Nutrition and Feed Science in South China, Ministry of Agriculture and Rural Affairs, State Key Laboratory of Livestock and Poultry Breeding, Guangdong Provincial Key Laboratory of Animal Breeding and Nutrition, Maoming Branch, Guangdong Laboratory for Lingnan Modern Agriculture, Guangdong Academy of Agricultural Sciences, Guangzhou, 510640, China
| | - Xiao-Ling Zhang
- ABI Group of GPM Project, Department of Marine Chemistry, College of Marine Science and Technology, Zhejiang Ocean University, Zhoushan, 316022, China
| | - Qiao Yang
- ABI Group of GPM Project, Department of Marine Chemistry, College of Marine Science and Technology, Zhejiang Ocean University, Zhoushan, 316022, China. .,Systems Biology Laboratory, Shanghai Ocean University, Shanghai, 201306, China.
| |
Collapse
|
17
|
Pan HF, Gong GW, Liu XX, Chu YQ, Zhang C, Wang G, Jiang ZW. [Clinical research of a continuous auscultation recorder based on artificial intelligence]. Zhonghua Yi Xue Za Zhi 2020; 100:3157-3160. [PMID: 33142398 DOI: 10.3760/cma.j.cn112137-20200303-00570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the feasibility and clinical significance of a continuous auscultation recorder of bowel sounds based on artificial intelligence in monitoring the bowel sounds. Methods: From November 1,2018 to August 12,2019, a continuous auscultation recorder of bowel sounds was applied to monitor the perioperative bowel sounds of 31 patients undergoing colorectal surgery, in order to discovery underlying rules which might be used to guide clinical practice. Results: After the operation, the bowel sounds continued to exist for (1.8±0.8) h, and then gradually weakened or disappeared, and recovered gradually after (11.2±3.5) h. The first exhaust and the first defecation were detected at the time of (22.7±5.8) h and (28.7±6.9) h after surgery, respectively. The bowel sounds rate increased after eating, and decreased significantly after exhaust/defecation. Conclusions: The continuous auscultation recorder of bowel sounds based on artificial intelligence was safe and effective, which can afford help to clinical evaluation.
Collapse
Affiliation(s)
- H F Pan
- Research Institute of General Surgery, Jinling Hospital of Nanjing Medical University(East War Zone Hospital), Nanjing 210002, China
| | - G W Gong
- Department of Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210002,China
| | - X X Liu
- Department of Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210002,China
| | - Y Q Chu
- Department of Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210002,China
| | - C Zhang
- Department of Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210002,China
| | - G Wang
- Department of Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210002,China
| | - Z W Jiang
- Research Institute of General Surgery, Jinling Hospital of Nanjing Medical University(East War Zone Hospital), Nanjing 210002, China
| |
Collapse
|
18
|
Zhi MW, Dai XJ, Jiang ZW, Xu SS, Li M, Xie RY. [Effect of acupoint application therapy at different timing points on gastrointestinal function recovery and heart rate variability after laparoscopic resection of colorectal cancer]. Zhongguo Zhen Jiu 2020; 40:947-52. [PMID: 32959589 DOI: 10.13703/j.0255-2930.20200327-k0003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECTIVE To observe the effect of acupoint application therapy at different timing points on the gastrointestinal function recovery and heart rate variability (HRV) after laparoscopic resection of colorectal cancer under the instruction of enhanced recovery after surgery (ERAS). METHODS A total of 105 patients for the selective laparoscopic resection of colorectal cancer were selected and randomized into a preoperative acupoint application group (35 cases, 3 cases dropped off), a postoperative acupoint application group (35 cases, 1 case dropped out) and a control group (35 cases, 2 cases dropped off). In the control group, ERAS interventions were provided, such as health education, fluid supplementation and multi-mode analgesia. On the base of the treatment as the control group, in the preoperative acupoint application group and the postoperative acupoint application group, 3 days before operation and 6 h after operation, the acupoint application therapy was given respectively. The acupoints were Zusanli (ST 36), Shangjuxu (ST 37), Sanyinjiao (SP 6), Neiguan (PC 6) and Xiajuxu (ST 39). The acupoint application was exerted for 6 h each time, once daily till the first postoperative exhaust and defecation presented. It was to observe the time of the first postoperative exhaust, defecation and food intake, the score of visual analogue scale (VAS) 1 to 3 days after operation, the total score of gastrointestinal symptom rating scale (GSRS) before and 1 week after operation, as well as the related indicators of HRV [standard deviation of NN intervals (SDNN) and the ratio of low-frequency power and high frequency power (LF/HF)] in the three groups successively. Besides, the adverse reactions were recorded during intervention in the three groups. RESULTS Compared with the control group, the time of the first postoperative exhaust and the time of the first postoperative defecation were all earlier in the preoperative acupoint application group and the postoperative acupoint application group respectively (P<0.05), and VAS scores 1 to 3 days after operation and total GSRS scores 1 week after operation were all reduced (P<0.05); the time of first food intake was earlier after operation (P<0.05), and SDNN and LF/LF were increased 1 day and 3 days after operation in the preoperative acupoint application group (P<0.05). Compared with the postoperative acupoint application group, in the preoperative acupoint application group, the time of the first postoperative exhaust and the time of the first postoperative defecation were all earlier (P<0.05), VAS scores were reduced in 1 to 3 days after operation (P<0.05), and SDNN 1 day and 3 days after operation and LF/HF 1 day after operation were all increased (P<0.05). No adverse reaction was detected in patients of the three groups. CONCLUSION Under the instruction of ERAS, the preoperative acupoint application effectively promotes the postoperative gastrointestinal function recovery, improves HRV and autonomous nerve function in the patients after laparoscopic resection of colorectal cancer. The therapeutic effect of this therapy is better than the postoperative acupoint application.
Collapse
Affiliation(s)
- Meng-Wei Zhi
- School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu Province, China
| | - Xin-Juan Dai
- Department of Nursing, 3Department of General Surgery, Jiangsu Provincial TCM Hospital, Nanjing 210029
| | - Zhi-Wei Jiang
- Department of General Surgery, Jiangsu Provincial TCM Hospital, Nanjing 210029
| | - Shan-Shan Xu
- Department of Nursing, 3Department of General Surgery, Jiangsu Provincial TCM Hospital, Nanjing 210029
| | - Min Li
- Department of Nursing, 3Department of General Surgery, Jiangsu Provincial TCM Hospital, Nanjing 210029
| | - Rui-Yi Xie
- Department of Nursing, 3Department of General Surgery, Jiangsu Provincial TCM Hospital, Nanjing 210029
| |
Collapse
|
19
|
Yan BH, Jiang ZW, Zeng JP, Tang JY, Ding H, Xia JL, Qin SR, Jin SC, Lu Y, Zhang N, Wang ZH, Li HY, Sang XY, Wu LN, Tang SY, Li Y, Tao MY, Wang QL, Wang JD, Xie HY, Chen QY, Yang SW, Hu NS, Yang JQ, Bao XX, Zhang Q, Yang XL, Jiang CY, Luo HY, Cai ZH, Yu SG. [Large- scale prospective clinical study on prophylactic intervention of COVID-19 in community population using Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules]. Zhongguo Zhong Yao Za Zhi 2020; 45:2993-3000. [PMID: 32726003 DOI: 10.19540/j.cnki.cjcmm.20200430.501] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
To scientifically evaluate the intervention effect of Chinese medicine preventive administration(combined use of Huo-xiang Zhengqi Oral Liquid and Jinhao Jiere Granules) on community population in the case of coronavirus disease 2019(COVID-19), a large cohort, prospective, randomized, and parallel-controlled clinical study was conducted. Total 22 065 subjects were included and randomly divided into 2 groups. The non-intervention group was given health guidance only, while the traditional Chinese medicine(TCM) intervention group was given two coordinated TCM in addition to health guidance. The medical instructions were as follows. Huoxiang Zhengqi Oral Liquid: oral before meals, 10 mL/time, 2 times/day, a course of 5 days. Jinhao Jiere Granules: dissolve in boiling water and take after meals, 8 g/time, 2 times/day, a course of 5 days, followed up for 14 days, respectively. The study found that with the intake of medication, the incidence rate of TCM intervention group was basically maintained at a low and continuous stable level(0.01%-0.02%), while the non-intervention group showed an overall trend of continuous growth(0.02%-0.18%) from 3 to 14 days. No suspected or confirmed COVID-19 case occurred in either group. There were 2 cases of colds in the TCM intervention group and 26 cases in the non-intervention group. The incidence of colds in the TCM intervention group was significantly lower(P<0.05) than that in the non-intervention group. In the population of 16-60 years old, the incidence rate of non-intervention and intervention groups were 0.01% and 0.25%, respectively. The difference of colds incidence between the two groups was statistically significant(P<0.05). In the population older than 60 years old, they were 0.04% and 0.21%, respectively. The incidence of colds in the non-intervention group was higher than that in the intervention group, but not reaching statistical difference. The protection rate of TCM for the whole population was 91.8%, especially for the population of age 16-60(95.0%). It was suggested that TCM intervention(combined use of Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules) could effectively protect community residents against respiratory diseases, such as colds, which was worthy of promotion in the community. In addition, in terms of safety, the incidence of adverse events and adverse reactions in the TCM intervention group was relatively low, which was basically consistent with the drug instructions.
Collapse
Affiliation(s)
- Bo-Hua Yan
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Zhi-Wei Jiang
- Beijing Key Tech Statistical Consulting Co., Ltd. Beijing 100015, China
| | - Jie-Ping Zeng
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Jian-Yuan Tang
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Hong Ding
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Jie-Lai Xia
- Air Force Military Medical University of People's Liberation Army Xi'an 710032, China
| | | | - Si-Cen Jin
- Taiji Group Co., Ltd. Chongqing 408000, China
| | - Yun Lu
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Na Zhang
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Zhi-Hong Wang
- Chengdu Zhongxiang Pharmaceutical Technology Co., Ltd. Chengdu 610000, China
| | - Hai-Yan Li
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Xiao-Ya Sang
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Li-Na Wu
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Shi-Yun Tang
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Yan Li
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Meng-Yao Tao
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Qiao-Ling Wang
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Jun-Dong Wang
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Hong-Yan Xie
- Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075,China
| | - Qi-Yuan Chen
- Yingmenkou Community Service Center Chengdu 610036, China
| | | | - Nian-Shuang Hu
- Jiangxijie Community Service Center Chengdu 610041, China
| | | | - Xiao-Xia Bao
- Caoshi Yuhe Community Service Center Chengdu 610014, China
| | - Qiong Zhang
- Shuangnan Community Service Center Chengdu 610047, China
| | - Xiao-Li Yang
- Yulin Community Service Center Chengdu 610044, China
| | | | - Hong-Yan Luo
- Caotang Community Service Center Chengdu 610072, China
| | - Zheng-Hua Cai
- Xinhua Shaocheng Community Service Center Chengdu 610014, China
| | - Shu-Guang Yu
- Chengdu University of Traditional Chinese Medicine Chengdu 611137, China
| |
Collapse
|
20
|
Wei XM, Chen XF, Shu P, Jiang ZW, Wu XY, Zou X, Chen K, Shen B, Hu WW, Lu W, Shen WX, Li L, Wang JY, Zhao FJ, Yin QF, Cheng HB, Gu YH. Study on efficacy and safety of Huangqi Guizhi Wuwu decoction treatment for oxaliplatin induced peripheral neurotoxicity: A protocol for a randomized, controlled, double-blind, multicenter trial. Medicine (Baltimore) 2020; 99:e19923. [PMID: 32481364 DOI: 10.1097/md.0000000000019923] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
BACKGROUND Oxaliplatin can cause severe peripheral neurotoxicity, which is an important reason for clinical oxaliplatin reduction and cessation of treatment. Oxaliplatin induced peripheral neurotoxicity (OIPN) can cause paresthesia and dysesthesia, even affect the quality life of patients. So far, there are no recognized and effective measures to prevent OIPN. Huangqi Guizhi Wuwu decoction is a classical prescription of ancient Chinese medicine recorded in "the synopsis of the Golden Chamber," which can be used in the treatment of various neurotoxicity. However, there is a lack of large-scale and high-quality clinical studies on the prevention of OIPN by Huangqi Guizhi Wuwu decoction. The purpose of this study is to evaluate the efficacy and safety of Huangqi Guizhi Wuwu decoction on preventing OIPN. METHODS/DESIGN This study is a randomized, controlled, double-blind, and multicenter clinical trial. Three hundred sixty patients will be randomly assigned into Huangqi Guizhi Wuwu decoction group and Huangqi Guizhi Wuwu decoction mimetic agent group. Patients will receive chemotherapy with FOLFOX of 8 cycles of 3 weeks with Traditional Chinese Medicine (TCM) for 6 months and 1-year follow-up. The primary outcome measure is the differences in the incidence of chronic neurotoxicity of grade 2 and above during and after treatment. The secondary outcome measure is the improvement in other symptoms associated with chemotherapy. Four methods will be used to evaluate the efficacy of neurotoxicity, including oxaliplatin specific toxicity grading standard (Levi classification); CTCAE4.02 version; EORTC QLQ-CIPN20 scale, EORTC QLQ C30 scale, and EORTC QLQ-CR29 scale are used at the same time; Electromyography. DISCUSSION This study will provide objective evidences to evaluate the efficacy and safety of Huangqi Guizhi Wuwu Decoction on preventing OIPN. TRIAL REGISTRATION Clinical Trials.gov (Identifier: NCT04261920).
Collapse
Affiliation(s)
- Xiao-Man Wei
- The First Clinical College of Nanjing University of Chinese Medicine
- Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor
| | - Xiao-Feng Chen
- Department of Oncology, The First Affiliated Hospital With Nanjing Medical University
- Department of Oncology, Pukou Branch Hospital of Jiangsu Province Hospital (Nanjing Pukou Central Hospital)
| | - Peng Shu
- Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine
| | - Zhi-Wei Jiang
- Department of General Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine
| | - Xiao-Yu Wu
- Department of Surgical Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine
| | - Xi Zou
- Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine
| | - Kai Chen
- Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou
| | - Bo Shen
- Department of Oncology, Jiangsu Cancer Hospital
| | - Wen-Wei Hu
- Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou
| | - Wei Lu
- Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine
| | - Wei-Xing Shen
- The First Clinical College of Nanjing University of Chinese Medicine
- Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor
| | - Liu Li
- The First Clinical College of Nanjing University of Chinese Medicine
- Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor
| | - Jun-Yi Wang
- Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine
| | - Feng-Jiao Zhao
- Department of Oncology, The First Affiliated Hospital With Nanjing Medical University
| | - Qing-Feng Yin
- Jiangsu Famous Medical Technology Co., Ltd, Nanjing University of Chinese Medicine, Nanjing, China
| | - Hai-Bo Cheng
- The First Clinical College of Nanjing University of Chinese Medicine
- Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor
| | - Yan-Hong Gu
- Department of Oncology, The First Affiliated Hospital With Nanjing Medical University
| |
Collapse
|
21
|
Guan X, Liu Z, Parvaiz A, Longo A, Saklani A, Shafik AA, Cai JC, Ternent C, Chen L, Kayaalp C, Sumer F, Nogueira F, Gao F, Han FH, He QS, Chun HK, Huang CM, Huang HY, Huang R, Jiang ZW, Khan JS, da JM, Pereira C, Nunoo-Mensah JW, Son JT, Kang L, Uehara K, Lan P, Li LP, Liang H, Liu BR, Liu J, Ma D, Shen MY, Islam MR, Samalavicius NE, Pan K, Tsarkov P, Qin XY, Escalante R, Efetov S, Jeong SK, Lee SH, Sun DH, Sun L, Garmanova T, Tian YT, Wang GY, Wang GJ, Wang GR, Wang XQ, Chen WTL, Yong Lee W, Yan S, Yang ZL, Yu G, Yu PW, Zhao D, Zhong YS, Wang JP, Wang XS. International consensus on natural orifice specimen extraction surgery (NOSES) for gastric cancer (2019). Gastroenterol Rep (Oxf) 2020; 8:5-10. [PMID: 32104581 PMCID: PMC7034234 DOI: 10.1093/gastro/goz067] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/03/2019] [Revised: 11/16/2019] [Accepted: 11/21/2019] [Indexed: 02/06/2023] Open
Abstract
At present, natural orifice specimen extraction surgery (NOSES) has attracted more and more attention worldwide, because of its great advantages including minimal cutaneous trauma and post-operative pain, fast post-operative recovery, short hospital stay, and positive psychological impact. However, NOSES for the treatment of gastric cancer (GC) is still in its infancy, and there is great potential to improve its theoretical system and clinical practice. Especially, several key points including oncological outcomes, bacteriological concerns, indication selection, and standardized surgical procedures are raised with this innovative technique. Therefore, it is necessary to achieve an international consensus to regulate the implementation of GC-NOSES, which is of great significance for healthy and orderly development of NOSES worldwide.
Collapse
Affiliation(s)
- Xu Guan
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
| | - Zheng Liu
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
| | | | - Antonio Longo
- European Center of Coloproctology and Pelvic Diseases-Multimedica Hospital, Milan, Italy
| | - Avanish Saklani
- Department of GI Surgical Oncology, Tata Memorial Hospital, Mumbai, India
| | - Ali A Shafik
- Department of Colorectal Surgery, Cairo University, Cairo, Egypt
| | - Jian-Chun Cai
- Department of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, Xiamen, Fujian, P. R. China
| | - Charles Ternent
- Section of Colon and Rectal Surgery, Creighton University School of Medicine, Omaha, NE, USA
| | - Lin Chen
- Department of General Surgery, Chinese People's Liberation Army General Hospital, Beijing, P. R. China
| | - Cuneyt Kayaalp
- Department of Gastrointestinal Surgery, Inonu University, Malatya, Turkey
| | - Fatih Sumer
- Department of Gastrointestinal Surgery, Inonu University, Malatya, Turkey
| | | | - Feng Gao
- Department of Colorectal Cancer Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, P. R. China
| | - Fang-Hai Han
- Department of Gastroenterological Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China
| | - Qing-Si He
- Department of General Surgery, Shandong University Qilu Hospital, Jinan, Shandong, P. R. China
| | - Ho-Kyung Chun
- Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Chang-Ming Huang
- Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, P. R. China
| | - Hai-Yang Huang
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
| | - Rui Huang
- Department of Colorectal Cancer Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, P. R. China
| | - Zhi-Wei Jiang
- Department of General Surgery, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, P. R. China
| | - Jim S Khan
- Department of Colorectal Surgery, Portsmouth, Hospitals NHS, Trust, Queen Alexandra Hospital, Portsmouth, UK
| | - Joaquim Manuel da
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.,Poole Hospital NHS Trust, Poole, UK.,European Center of Coloproctology and Pelvic Diseases-Multimedica Hospital, Milan, Italy.,Department of GI Surgical Oncology, Tata Memorial Hospital, Mumbai, India.,Department of Colorectal Surgery, Cairo University, Cairo, Egypt.,Department of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, Xiamen, Fujian, P. R. China.,Section of Colon and Rectal Surgery, Creighton University School of Medicine, Omaha, NE, USA.,Department of General Surgery, Chinese People's Liberation Army General Hospital, Beijing, P. R. China.,Department of Gastrointestinal Surgery, Inonu University, Malatya, Turkey.,Department of Surgery, Hospital de Braga, Braga, Portugal.,Department of Colorectal Cancer Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, P. R. China.,Department of Gastroenterological Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.,Department of General Surgery, Shandong University Qilu Hospital, Jinan, Shandong, P. R. China.,Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.,Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, P. R. China.,Department of General Surgery, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, P. R. China.,Department of Colorectal Surgery, Portsmouth, Hospitals NHS, Trust, Queen Alexandra Hospital, Portsmouth, UK.,King's College Hospital, London, UK.,Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.,Division of Surgical Oncology, Department of Surgery, Nagoya University School of Medicine, Nagoya, Japan.,Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, P. R. China.,Department of Gastric Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, P. R. China.,Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China.,Department of Obstetrics and Gynecology, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, P. R. China.,Department of General Surgery, Xinqiao, Hospital, Third Military Medical University, Chongqing, P. R. China.,Department of Surgery, China Medical University Hospital, Taichung, Taiwan, China.,Department of Surgery, Shaheed Suhrawardy Medical College, Dhaka, Bangladesh.,Department of Surgery, Klaipeda University Hospital, Klaipeda, Lithuania.,Department of Gastrointestinal Surgery, Shenzhen People's Hospital & Second Clinical Medical College of Jinan University, Shenzhen, Guangdong, P. R. China.,Clinic of Colorectal and Minimally Invasive Surgery, Sechenov First Moscow State Medical University, Moscow, Russia.,Department of General Surgery, Zhongshan, Hospital, Fudan University, Shanghai, P. R. China.,Universidad Central de Venezuela, Centro, Medico Loira, Caracas, Venezuela.,Colorectal Surgery Department, Sechenov First Moscow State Medical University, Moscow, Russia.,Department of Surgery, Yang Hospital, Seoul, South Korea.,Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, South Korea.,Department of Gastric and Colorectal Surgery, Jilin University First Hospital, Changchun, Jilin, P. R. China.,Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.,Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.,Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China.,Department of General Surgery, Shanxi, Provincial, People's, Hospital, The, Third Affiliated, Hospital, Medical College, Xi'an Jiao Tong University, Xi'an, Shaanxi, P. R. China.,Department of surgery, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea.,Department of Gastrointestinal Surgery, Qinghai University Affiliated Hospital, Xining, Qinghai, P. R. China.,Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.,Department of General Surgery, Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, P. R. China.,Department of General Surgery, Center of Minimal Invasive Gastrointestinal Surgery, Southwest, Hospital, Army Medical University (Third Military Medical University), Chongqing, P. R. China.,Endoscopy Center and Endoscopy Research Institute, Zhongshan, Hospital, Fudan University, Shanghai, P. R. China
| | - Costa Pereira
- Department of Surgery, Hospital de Braga, Braga, Portugal
| | | | - Jung Tack Son
- Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Liang Kang
- Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China
| | - Keisuke Uehara
- Division of Surgical Oncology, Department of Surgery, Nagoya University School of Medicine, Nagoya, Japan
| | - Ping Lan
- Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China
| | - Le-Ping Li
- Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, P. R. China
| | - Han Liang
- Department of Gastric Cancer, Tianjin Medical University Cancer Institute & Hospital, Tianjin, P. R. China
| | - Bing-Rong Liu
- Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China
| | - Juan Liu
- Department of Obstetrics and Gynecology, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, P. R. China
| | - Dan Ma
- Department of General Surgery, Xinqiao, Hospital, Third Military Medical University, Chongqing, P. R. China
| | - Ming-Yin Shen
- Department of Surgery, China Medical University Hospital, Taichung, Taiwan, China
| | | | | | - Kai Pan
- Department of Gastrointestinal Surgery, Shenzhen People's Hospital & Second Clinical Medical College of Jinan University, Shenzhen, Guangdong, P. R. China
| | - Petr Tsarkov
- Clinic of Colorectal and Minimally Invasive Surgery, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Xin-Yu Qin
- Department of General Surgery, Zhongshan, Hospital, Fudan University, Shanghai, P. R. China
| | - Ricardo Escalante
- Universidad Central de Venezuela, Centro, Medico Loira, Caracas, Venezuela
| | - Sergey Efetov
- Colorectal Surgery Department, Sechenov First Moscow State Medical University, Moscow, Russia
| | | | - Suk-Hwan Lee
- Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, South Korea
| | - Dong-Hui Sun
- Department of Gastric and Colorectal Surgery, Jilin University First Hospital, Changchun, Jilin, P. R. China
| | - Li Sun
- Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
| | - Tatiana Garmanova
- Clinic of Colorectal and Minimally Invasive Surgery, Sechenov First Moscow State Medical University, Moscow, Russia
| | - Yan-Tao Tian
- Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
| | - Gui-Yu Wang
- Department of Colorectal Cancer Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, P. R. China
| | - Guo-Jun Wang
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China
| | - Guo-Rong Wang
- Department of General Surgery, Shanxi, Provincial, People's, Hospital, The, Third Affiliated, Hospital, Medical College, Xi'an Jiao Tong University, Xi'an, Shaanxi, P. R. China
| | - Xiao-Qiang Wang
- Department of General Surgery, Shanxi, Provincial, People's, Hospital, The, Third Affiliated, Hospital, Medical College, Xi'an Jiao Tong University, Xi'an, Shaanxi, P. R. China
| | | | - Woo Yong Lee
- Department of surgery, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea
| | - Su Yan
- Department of Gastrointestinal Surgery, Qinghai University Affiliated Hospital, Xining, Qinghai, P. R. China
| | - Zu-Li Yang
- Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China
| | - Gang Yu
- Department of General Surgery, Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, P. R. China
| | - Pei-Wu Yu
- Department of General Surgery, Center of Minimal Invasive Gastrointestinal Surgery, Southwest, Hospital, Army Medical University (Third Military Medical University), Chongqing, P. R. China
| | - Dan Zhao
- Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
| | - Yun-Shi Zhong
- Endoscopy Center and Endoscopy Research Institute, Zhongshan, Hospital, Fudan University, Shanghai, P. R. China
| | - Jian-Ping Wang
- Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China
| | - Xi-Shan Wang
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
| |
Collapse
|
22
|
He MF, Jiang ZW, Hao ZW, An J, Zhai J, Shen JK. [Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer: a meta-analysis]. Zhonghua Wei Chang Wai Ke Za Zhi 2020; 22:1196-1204. [PMID: 31874538 DOI: 10.3760/cma.j.issn.1671-0274.2019.12.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To systematically evaluate the diagnostic value of optical imaging combined with indocyanine green (ICG)-guided sentinel lymph node (SLN) biopsy in gastric cancer, and to identify potential factors that would influence diagnostic accuracy. Methods: Study was carried out by searching the electronic database of PubMed, Embase, Medline, Web of Science, and the Cochrane Library with keywords as "gastric/stomach" and "cancer/carcinoma/tumor/tumour/adenocarcinoma/neoplasm" and "sentinel lymph node" and "near-infrared/NIR or fluorescent imaging" and "indocyanine green/ICG" . Literature inclusion criteria: (1) gastric cancer clinical stage was cT0-3; (2) clinical stage determined by at least 2 kinds of imaging modalities; (3) optical imaging (near-infrared or fluorescence imaging) combined with ICG-guided SLN biopsy; (4) prospective study to predict lymph node metastasis; (5) intraoperative or postoperative pathology for all lymph nodes removed; (6) patients number in the literature >10 cases. Exclusion criteria: (1) patients with a history of ICG allergy or chemoradiotherapy; (2) previous history of endoscopic mucosal resection or endoscopic submucosal dissection; (3) patients with a variety of gastrointestinal tumor; (4) case reports, conference abstracts, clinical guidelines, editorials, reviews, meta-analysis and correspondence letters; (5) in vitro or animal experiments; (6) insufficient diagnostic efficacy data. The meta-analysis was performed in the Stata12.0 software using the "bivariate mixed-effects model" combined with the "midas" command to pool the data. Information such as true positive value, false positive value, false negative value, and true negative value of each included articles were extracted. The literature quality assessment map was drawn to describe the overall quality of the articles; the heterogeneity analysis was performed with the forest map, with P<0.01 considered as statistical significance; the funnel plot was used to describe publication bias, with P<0.1 considered as statistically significant. Area under curve (AUC) of summary receiver operator characteristic (SROC) was used to describe the diagnostic accuracy and the AUC closer to 1 indicated higher diagnostic accuracy. If there was heterogeneity (I(2)>50%) among studies, regression analysis and subgroup analysis were performed. P<0.05 was considered as statistically significant. Results: A total of 15 studies (1020 patients) were included. The optical imaging contained near-infrared (NIR) and fluorescent imaging (FI). The diagnostic value of optical imaging combined with ICG-guided SLN biopsy in gastric cancer was as follows: the pooled sensitivity (Sen) was 0.95 (95% CI: 0.82 to 0.99), specificity (Spe) was 1.00 (95% CI: 0.92 to 1.00), positive likelihood ratio (PLR) was 30.39 (95% CI: 9.14 to 101.06), negative likelihood ratio (NLR) was 0.05 (95% CI:0.01 to 0.20), diagnostic odds ratio (DOR) was 225.54 (95% CI: 88.81 to 572.77), AUC was 1.00 (95% CI: 0.99 to 1.00), threshold value was sensitivity=0.95 (95% CI: 0.82 to 0.99) and specificity=1.00 (95% CI: 0.92 to 1.00). Deeks method revealed DOR funnel plot of SLN biopsy was not asymmetrical obviously with significant difference (P=0.01), which indicated remarkable publishing bias. Meta-subgroup analysis showed that compared to FI, NIR imaging had higher sensitivity (0.98 vs. 0.73); compared to 0 minutes, optical imaging performed 20 minutes after ICG injection had higher sensitivity (0.98 vs. 0.70); compared to mean detected number of SLN of 4, mean detected number≥4 had higher sensitivity (0.96 vs. 0.68); compared to HE stain, immunohistochemistry + HE had higher sensitivity (0.99 vs. 0.84); compared to subserous injection of ICG, submucosa injection of ICG had higher sensitivity (0.98 vs. 0.40); compared to injection of 5 g/L ICG, 0.5 g/L and 0.05 g/L had higher sensitivity (0.98 vs. 0.83); compared to cT2-3 tumor, early stage (cT1) tumor had higher sensitivity (0.96 vs. 0.72); compared to ≤ enrolled 26 cases in the study, > 26 cases had higher sensitivity (0.96 vs. 0.65); compared to papers before 2010, papers after 2010 had higher sensitivity (0.97 vs. 0.81); whose differences were all significant. Sensitivity differences between mean tumor diameter of ≤30 cm and >30 cm, open surgery and laparoscopic surgery, lymph node regional dissection and retrieved dissection were not significant (all P>0.05). Conclusions: Optical imaging combined with ICG-guided SLN biopsy is clinically feasible, and especially suitable for early gastric cancer. However, the ICG being used in current studies may be overdosed. Higher sensitivity may be achieved from NIR imaging when compared with FI method.
Collapse
Affiliation(s)
- M F He
- Department of Graduate School, Chengde Medical University, Hebei Chengde 067000, China
| | - Z W Jiang
- The Second Department of General Surgery, Baoding First Central Hospital, Hebei Baoding 071000, China
| | - Z W Hao
- The Second Department of General Surgery, Baoding First Central Hospital, Hebei Baoding 071000, China
| | - J An
- The Second Department of General Surgery, Baoding First Central Hospital, Hebei Baoding 071000, China
| | - J Zhai
- The Second Department of General Surgery, Baoding First Central Hospital, Hebei Baoding 071000, China
| | - J K Shen
- The Second Department of General Surgery, Baoding First Central Hospital, Hebei Baoding 071000, China
| |
Collapse
|
23
|
Zhou RM, Shao B, Luo C, Dai HY, Xu J, Li XY, Wang N, Zhang RX, Ji F, Yang B, Jiang ZW, Hu F, Liu SP, Yao JJ, Liu Y, Zhou YW, Guan JX, Xiao ZM, Lu ZN. [Analysis of differences in epidemiology and clinical features of Guillain-Barré syndrome between rural and urban areas of southern China]. Zhonghua Yi Xue Za Zhi 2019; 99:3432-3436. [PMID: 31752474 DOI: 10.3760/cma.j.issn.0376-2491.2019.43.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Objective: To explore the differences in epidemiology and clinical features of Guillain- Barré syndrome (GBS) between rural and urban areas of southern China. Methods: The clinical data of 759 hospitalized GBS patients from 31 hospitals of 13 provinces/cities in southern China, between January 1st, 2013 and September 30th, 2016, were collected and analyzed retrospectively. Results: The risk of GBS was higher for males than females in rural and urban areas and the median age was 49 and 48 years, respectively. Seasonal clustering in winter and spring was noted in both rural and urban areas, and the seasonal trend was more markedly in rural areas, but the differences showed no statistical significance. There were 70.37% of patients in rural areas and 73.69% in urban areas who had antecedent respiratory infection. The median time from onset to nadir was 7 days, and Hughes Disability Scale at admission, nadir and discharge were (2.95±1.10 vs 2.84±1.15), (3.25±1.11 vs 3.14±1.21), (2.02±1.24 vs 2.00±1.31) in rural and urban areas respectively. Albuminocytologic dissociation was present in 84.34% of patients in rural areas and 84.62% of cases in urban areas. There were 8.65% and 10.94% of cases in rural and urban areas who required mechanical ventilation during hospitalization, respectively. Demyelinating GBS accounted for 53.29% and 48.77%, respectively, in patients with findings of nerve conduction studies available in rural and urban areas. Conclusions: GBS in rural areas of southern China showed male predominance and a peak of spring and winter occurrence, with respiratory infection as the predominated preceding events and demyelinating GBS being main clinical subtype. Winter and spring showed a higher incidence of GBS in rural and urban areas. There were no significant differences of sex, age, preceding events, season trend, progression of disease, clinical subtypes and cerebrospinal fluid investigations in GBS patients between rural and urban areas.
Collapse
Affiliation(s)
- R M Zhou
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China
| | - B Shao
- Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
| | - C Luo
- Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - H Y Dai
- Department of Neurology, Sichuan Provincial People's Hospital, Chengdu 410072, China
| | - J Xu
- Department of Neurology, Northern Jiangsu People's Hospital, Yangzhou 225001, China
| | - X Y Li
- Department of Neurology, Guizhou Provincial People's Hospital, Guiyang 550002, China
| | - N Wang
- Department of Neurology, Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan 442000, China
| | - R X Zhang
- Department of Neurology, the Third Xiangya Hospital of Central South University, Changsha 410000, China
| | - F Ji
- Department of Neurology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China
| | - B Yang
- Department ofNeurology, Yichang Central People's Hospital, China Three Gorges University, Yichang 443003, China
| | - Z W Jiang
- Department of Neurology, the First Affiliated Hospital of Yangtze University, Jingzhou 434000, China
| | - F Hu
- Department of Neurology, Jiangxi Provincial People's Hospital, Nanchang 330006, China
| | - S P Liu
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China
| | - J J Yao
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China
| | - Y Liu
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China
| | - Y W Zhou
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China
| | - J X Guan
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China
| | - Z M Xiao
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China
| | - Z N Lu
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China
| |
Collapse
|
24
|
Huang TB, Li YZ, Yu K, Yu Z, Wang Y, Jiang ZW, Wang HM, Yang GL. Effect of the Wnt signal-RANKL/OPG axis on the enhanced osteogenic integration of a lithium incorporated surface. Biomater Sci 2019; 7:1101-1116. [PMID: 30633253 DOI: 10.1039/c8bm01411f] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Bone remolding involves the formation of new bone by osteoblasts and the absorption of old bones by osteoclasts. Due to the vital role of osteoblasts and osteoclasts during bone regeneration, it might be feasible to promote osseointegration around the titanium implants by stimulating osteoblasts and inhibiting osteoclasts by modifying the surfaces of the implants. Lithium is used in the treatment of psychiatric patients, and it may be associated with osteogenesis. In this study, lithium was incorporated with sandblasted, large-grit and acid-etched titanium implants via a hydrothermal treatment. In vitro, the nano-scale surface enhanced the adhesion and proliferation of bone marrow mesenchymal stem cells (BMSCs). Moreover, the SLA-Li surface displayed a negative effect on the process of osteoclastogenesis. Further mechanism analysis indicated that the canonical Wnt/β-catenin signaling pathway was activated according to the results of RT-PCR and western blotting. More importantly, the RANKL/OPG signaling axis was also involved in these effects on the SLA-Li surface. The experiments in vivo proved that the SLA-Li surface could induce the bone formation and osseointegration during the early osseointegration after the dental implant surgery. These results suggested that bone homeostasis could be manipulated by an SLA-Li surface, which implied that this new surface might serve as a promising material for clinical application in the future.
Collapse
Affiliation(s)
- Ting-Ben Huang
- Department of Implantology, Stomatology Hospital, School of Medicine, Zhejiang University, Yan'an Road, Hangzhou, P. R. China.
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Qin SY, Ding WQ, Jiang ZW, Lei X, Zhang AQ. Directing an oligopeptide amphiphile into an aligned nanofiber matrix for elucidating molecular structures. Chem Commun (Camb) 2019; 55:1659-1662. [PMID: 30657473 DOI: 10.1039/c8cc09548e] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
A novel aligned nanofiber matrix was obtained from the self-assembly of an oligopeptide amphiphile. The alignment properties can be applied to measure residual dipolar couplings (RDCs) for the structural elucidation of molecules by liquid-state NMR.
Collapse
Affiliation(s)
- Si-Yong Qin
- School of Chemistry and Materials Science, South-Central University for Nationalities, Wuhan 430074, China.
| | | | | | | | | |
Collapse
|
26
|
Li Y, Li GX, Chu ZH, Hao CY, Jiang ZW, Chen HQ, Lin JJ, Li DC, Hu B, Wang XS, Lin F. Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study. J Cancer Res Ther 2018; 14:772-779. [PMID: 29970651 DOI: 10.4103/jcrt.jcrt_738_17] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Aim The aim of this is study is to assess the efficacy and safety of conversion capecitabine plus oxaliplatin (XELOX) in Chinese patients with potentially resectable colorectal liver metastases (CLMs). Patients and Methods Thirty patients (median age 57.5 years) with potentially resectable CLMs were treated with XELOX in a single-arm, open-label, nonrandomized, multicenter clinical trial. Results The objective response rate in the 30 patients was 40% (95% confidence interval: 22.7%-59.4%), and the rate of conversion to resectable CLMs was 43.3%. Patients who underwent liver resection (n = 11) had a longer median progression-free survival and overall survival than those who did not. XELOX showed an acceptable safety profile. Conclusion XELOX may effectively convert potentially resectable CLM into resectable CLM, providing survival benefits with a favorable safety profile. Clinical Trials.gov identifier NCT 00997685.
Collapse
Affiliation(s)
- Yong Li
- Department of Gastrointestional Surgery, Guandong General Hospital, Guangzhou, Guangdong, China
| | - Guo-Xin Li
- Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
| | - Zhong-Hua Chu
- Department of Gastrointestional Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
| | - Chun-Yi Hao
- Department of Hepato-Pancreato-Biliary Surgery, Beijing Cancer Hospital and Institute, Beijing, China
| | - Zhi-Wei Jiang
- Research Institute of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu, China
| | - Huan-Qiu Chen
- Department of General surgery, Jiangsu Cancer Hospital, The Affiliated Cancer Hospital With Nanjing Medical University, Nanjing, Jiangsu, China
| | - Jian-Jiang Lin
- Department of Colorectal surgery, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
| | - De-Chuan Li
- Department of Colorectal surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
| | - Bing Hu
- Department of Medical Oncology, Anhui Provincial Hospital, Hefei, Anhui, China
| | - Xi-Shan Wang
- Department of Colorectal Surgery, The Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China
| | - Feng Lin
- Department of Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
| |
Collapse
|
27
|
Qin SY, Cheng YJ, Jiang ZW, Ma YH, Zhang AQ. Morphology control of self-deliverable nanodrug with enhanced anticancer efficiency. Colloids Surf B Biointerfaces 2018. [DOI: 10.1016/j.colsurfb.2018.02.054] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
28
|
Yang Q, Jiang ZW, Huang CH, Zhang RN, Li LZ, Yang G, Feng LJ, Yang GF, Zhang H, Zhang XL, Mu J. Hoeflea prorocentri sp. nov., isolated from a culture of the marine dinoflagellate Prorocentrum mexicanum PM01. Antonie Van Leeuwenhoek 2018; 111:1845-1853. [PMID: 29603043 DOI: 10.1007/s10482-018-1074-0] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/31/2017] [Accepted: 03/21/2018] [Indexed: 11/29/2022]
Abstract
A Gram-stain negative, aerobic, rod-shaped, non-motile, yellow-pigmented and non-spore-forming bacterial strain, designated PM5-8T, was isolated from a culture of a marine toxigenic dinoflagellate Prorocentrum mexicanum PM01. Strain PM5-8T grew at 15-35 °C (optimum, 25-30 °C) and pH 6-11 (optimum, 7.5-8). Cells required at least 1.5% (w/v) NaCl for growth, and can tolerate up to 7.0% with the optimum of 4%. Phylogenetic analysis based on 16S rRNA gene sequence revealed that the strain PM5-8T is closely related to members of the genus Hoeflea, with high sequence similarities with Hoeflea halophila JG120-1T (97.06%) and Hoeflea alexandrii AM1V30T (97.01%). DNA-DNA hybridization values between the isolate and other type strains of recognized species of the genus Hoeflea were between 11.8 and 25.2%, which is far below the value of 70% threshold for species delineation. The DNA G + C content was 50.3 mol%. The predominant cellular fatty acids of the strain were identified as summed feature 8 (C16:1 ω7c and/or C16:1 ω6c; 51.5%), C18:1 ω7c 11-methyl (20.7%), C16:0 (17.2%) and C18:0 (5.7%). The major respiratory quinone was Q-10. Polar lipids profiles contained phosphatidylcholine, phosphatidylglycerol, sulfoquinovosyl diacylglycerol, phosphatidylmono- methylethanolamine, phosphatidylethanolamine and four unidentified lipids. On the basis of the polyphasic taxonomic data presented, strain PM5-8T (= CCTCC AB 2016294T = KCTC 62490T) represents a novel species of the genus Hoeflea, for which the name Hoeflea prorocentri sp. nov. is proposed.
Collapse
Affiliation(s)
- Qiao Yang
- Laboratory of Marine Environment and Ecology, College of Marine Science and Technology, Zhejiang Ocean University, Zhoushan, 316022, People's Republic of China
| | - Zhi-Wei Jiang
- Laboratory of Marine Environment and Ecology, College of Marine Science and Technology, Zhejiang Ocean University, Zhoushan, 316022, People's Republic of China
| | - Cheng-Hui Huang
- Laboratory of Marine Environment and Ecology, College of Marine Science and Technology, Zhejiang Ocean University, Zhoushan, 316022, People's Republic of China
| | - Ruo-Nan Zhang
- Center of Research in Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin, 150076, People's Republic of China
| | - Ling-Zhi Li
- East China Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Shanghai, 200090, People's Republic of China
| | - Guang Yang
- Laboratory of Marine Environment and Ecology, College of Marine Science and Technology, Zhejiang Ocean University, Zhoushan, 316022, People's Republic of China
| | - Li-Juan Feng
- Laboratory of Marine Environment and Ecology, College of Marine Science and Technology, Zhejiang Ocean University, Zhoushan, 316022, People's Republic of China
| | - Guang-Feng Yang
- Key Laboratory of Marine Ecology and Environmental Sciences, Institute of Oceanology, Chinese Academy of Sciences, Qingdao, 266071, People's Republic of China
| | - Heng Zhang
- East China Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Shanghai, 200090, People's Republic of China
| | - Xiao-Ling Zhang
- Laboratory of Marine Environment and Ecology, College of Marine Science and Technology, Zhejiang Ocean University, Zhoushan, 316022, People's Republic of China.
| | - Jun Mu
- Laboratory of Marine Environment and Ecology, College of Marine Science and Technology, Zhejiang Ocean University, Zhoushan, 316022, People's Republic of China.
| |
Collapse
|
29
|
Dai HB, Wang ZC, Feng XB, Wang G, Li WY, Hang CH, Jiang ZW. Case report about a successful full robotic radical gastric cancer surgery with intracorporeal robot-sewn anastomosis in a patient with situs inversus totalis and a two-and-a-half-year follow-up study. World J Surg Oncol 2018; 16:41. [PMID: 29499701 PMCID: PMC5834864 DOI: 10.1186/s12957-018-1311-z] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2017] [Accepted: 01/08/2018] [Indexed: 12/19/2022] Open
Abstract
Background During the last decade, total laparoscopic and laparoscopic-assisted distal gastrectomy for gastric cancer patients has been developed as alternatives to open resection. In recent years, this minimally invasive surgery has been extended using robotic-assisted surgery. Case presentation Here, we report a surgical intervention using a Da Vinci surgical robot in which a lower two-third stomach resection with subsequent Billroth II gastrojejunostomy was performed. The patient was a 53-year-old male with complete situs inversus gastric cancer who had received 2 cycles of neo-adjuvant oxaliplatin combined with S-1 medication. The operation took 3 h in total without complications. The amount of bleeding was about 50 mL, and on day 5 after the operation, the patient was discharged. Conclusions This is the first report of a successful robot-assisted gastric cancer resection of advanced gastric cancer in a patient with the anatomical abnormality of situs inversus totalis.
Collapse
Affiliation(s)
- Hai-Bin Dai
- Department of Anesthesiology, Jinling Hospital, School of Medicine, Nanjing University, No 305 East Zhongshan Road, Nanjing, 210002, China
| | - Zhi-Chun Wang
- Department of Anesthesiology, Shuyang People's Hospital, Jiangsu, China
| | - Xiao-Bo Feng
- Department of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, No 305 East Zhongshan Road, Nanjing, 210002, China
| | - Gang Wang
- Department of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, No 305 East Zhongshan Road, Nanjing, 210002, China
| | - Wei-Yan Li
- Department of Anesthesiology, Jinling Hospital, School of Medicine, Nanjing University, No 305 East Zhongshan Road, Nanjing, 210002, China
| | - Chun-Hua Hang
- Department of Neurosurgery, Drum Tower Hospital, School of Medicine, Nanjing University, No.321 Zhongshan Road, Nanjing, 210008, China.
| | - Zhi-Wei Jiang
- Department of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, No 305 East Zhongshan Road, Nanjing, 210002, China.
| |
Collapse
|
30
|
Zhao J, Wang G, Jiang ZW, Jiang CW, Liu J, Xia CC, Li JS. Patients Administered Neoadjuvant Chemotherapy Could be Enrolled into an Enhanced Recovery after Surgery Program for Locally Advanced Gastric Cancer. Chin Med J (Engl) 2018; 131:413-419. [PMID: 29451145 PMCID: PMC5830825 DOI: 10.4103/0366-6999.225047] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2017] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND Most studies on enhanced recovery after surgery (ERAS) for gastric cancer exclude patients who received neoadjuvant chemotherapy. Here, we aimed to evaluate whether patients who received neoadjuvant chemotherapy can be enrolled into the ERAS program for locally advanced gastric cancer. METHODS From April 2015 to July 2017, 114 patients who received neoadjuvant chemotherapy for locally advanced gastric cancer were randomized into ERAS and standard care (SC) groups. Postoperative length of stay, complications, bowel function, and nutritional status were recorded. RESULTS: The postoperative length of stay of the ERAS group was shorter compared with that of the SC group (5.9 ± 5.6 vs. 8.1 ± 5.3 days, P = 0.037). The postoperative complication rate was 9.3% in the ERAS group and 11.5% in the SC group (P = 0.700). The time to first flatus (2.7 ± 2.0 vs. 4.5 ± 4.6 days, P = 0.010) and time to a semi-liquid diet (3.2 ± 2.1 vs. 6.3 ± 4.9 days, P < 0.001) in the ERAS group were shorter compared with those in the SC group. On the 10th day after surgery, the values of weight, total protein, albumin, and prealbumin of the ERAS group were lower compared with those of the SC group. CONCLUSIONS: Patients who received neoadjuvant chemotherapy could be enrolled into ERAS programs for locally advanced gastric cancer. The nutritional status of these patients was not adversely affected.
Collapse
Affiliation(s)
- Jian Zhao
- Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, China
| | - Gang Wang
- Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, China
| | - Zhi-Wei Jiang
- Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, China
| | - Chuan-Wei Jiang
- Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, China
| | - Jiang Liu
- Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, China
| | - Can-Can Xia
- Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, China
| | - Jie-Shou Li
- Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, China
| |
Collapse
|
31
|
Chen XY, Wu ZF, Wang XC, Dong XL, Zhu JF, Chen T, Xiao QW, Jiang ZW, Fu C. [Association between body mass index and its change and type 2 diabetes mellitus risk in a prospective study]. Zhonghua Liu Xing Bing Xue Za Zhi 2017; 37:1332-1335. [PMID: 27765120 DOI: 10.3760/cma.j.issn.0254-6450.2016.10.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the influence of body mass index (BMI) and its change on the incidence of type 2 diabetes mellitus (T2DM) in an adult cohort. Methods: A total of 3 043 subjects randomly selected among those without T2DM at baseline survey from the Rural Deqing Health Cohort Study were included into this study and follow up was conducted for 1 867 of them from July to November 2015. The subjects were divided into 3 groups according to their baseline BMI, normal group (BMI<24.0), overweight group (BMI: 24.0-27.9) and obese group (BMI≥28.0) and the subjects with stable weight (BMI change of-0.05 to + 0.05 per year) were used as the referent category. Cox proportional model was used to estimate associations between BMI, its changes and T2DM. Results: With an average of (8.68±1.25) person years, 213 new T2DM cases, including 125 females were detected, and incidence density was 13.14 per 1 000 person years. After adjusted for other covariates, the risk for incidence of T2DM was significantly higher in subjects with baseline BMI≥28.0 kg/m2 than those with baseline BMI<24.0 kg/m2 (aHR=2.12, 95% CI: 1.22-3.68), and weight gains were strongly associated with the incidence of T2DM in those with baseline BMI< 24.0 kg/m2 (aHR=2.21, 95%CI:1.17-4.17). Conclusion: Both BMI and its change were significantly associated with incidence of T2DM, especially in the population with BMI<24.0 kg/m2 at baseline.
Collapse
Affiliation(s)
- X Y Chen
- School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai 200032, China
| | - Z F Wu
- School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai 200032, China
| | - X C Wang
- Deqing County Center for Disease Prevention and Control, Huzhou 313200, China
| | - X L Dong
- Deqing County Center for Disease Prevention and Control, Huzhou 313200, China
| | - J F Zhu
- Deqing County Center for Disease Prevention and Control, Huzhou 313200, China
| | - T Chen
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1N6N5, Canada
| | - Q W Xiao
- School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai 200032, China
| | - Z W Jiang
- School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai 200032, China
| | - Chaowei Fu
- School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai 200032, China
| |
Collapse
|
32
|
Parisi A, Reim D, Borghi F, Nguyen NT, Qi F, Coratti A, Cianchi F, Cesari M, Bazzocchi F, Alimoglu O, Gagnière J, Pernazza G, D’Imporzano S, Zhou YB, Azagra JS, Facy O, Brower ST, Jiang ZW, Zang L, Isik A, Gemini A, Trastulli S, Novotny A, Marano A, Liu T, Annecchiarico M, Badii B, Arcuri G, Avanzolini A, Leblebici M, Pezet D, Cao SG, Goergen M, Zhang S, Palazzini G, D’Andrea V, Desiderio J. Minimally invasive surgery for gastric cancer: A comparison between robotic, laparoscopic and open surgery. World J Gastroenterol 2017; 23:2376-2384. [PMID: 28428717 PMCID: PMC5385404 DOI: 10.3748/wjg.v23.i13.2376] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/11/2016] [Revised: 01/23/2017] [Accepted: 03/15/2017] [Indexed: 02/06/2023] Open
Abstract
AIM To investigate the role of minimally invasive surgery for gastric cancer and determine surgical, clinical, and oncological outcomes.
METHODS This is a propensity score-matched case-control study, comparing three treatment arms: robotic gastrectomy (RG), laparoscopic gastrectomy (LG), open gastrectomy (OG). Data collection started after sharing a specific study protocol. Data were recorded through a tailored and protected web-based system. Primary outcomes: harvested lymph nodes, estimated blood loss, hospital stay, complications rate. Among the secondary outcomes, there are: operative time, R0 resections, POD of mobilization, POD of starting liquid diet and soft solid diet. The analysis includes the evaluation of type and grade of postoperative complications. Detailed information of anastomotic leakages is also provided.
RESULTS The present analysis was carried out of 1026 gastrectomies. To guarantee homogenous distribution of cases, patients in the RG, LG and OG groups were 1:1:2 matched using a propensity score analysis with a caliper = 0.2. The successful matching resulted in a total sample of 604 patients (RG = 151; LG = 151; OG = 302). The three groups showed no differences in all baseline patients characteristics, type of surgery (P = 0.42) and stage of the disease (P = 0.16). Intraoperative blood loss was significantly lower in the LG (95.93 ± 119.22) and RG (117.91 ± 68.11) groups compared to the OG (127.26 ± 79.50, P = 0.002). The mean number of retrieved lymph nodes was similar between the RG (27.78 ± 11.45), LG (24.58 ± 13.56) and OG (25.82 ± 12.07) approach. A benefit in favor of the minimally invasive approaches was found in the length of hospital stay (P < 0.0001). A similar complications rate was found (P = 0.13). The leakage rate was not different (P = 0.78) between groups.
CONCLUSION Laparoscopic and robotic surgery can be safely performed and proposed as possible alternative to open surgery. The main highlighted benefit is a faster postoperative functional recovery.
Collapse
|
33
|
Liu XX, Pan HF, Jiang ZW, Zhang S, Wang ZM, Chen P, Zhao Y, Wang G, Zhao K, Li JS. "Fast-track" and "Minimally Invasive" Surgery for Gastric Cancer. Chin Med J (Engl) 2017; 129:2294-300. [PMID: 27647187 PMCID: PMC5040014 DOI: 10.4103/0366-6999.190659] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
Background: Enhanced recovery after surgery (ERAS) protocols or fast-track (FT) programs enable a shorter hospital stay and lower complication rate. Minimally invasive surgery (MIS) is associated with a lesser trauma and a quicker recovery in many elective abdominal surgeries. However, little is known of the safety and effectiveness made by ERAS protocols combined with MIS for gastric cancer. The purpose of this study was to evaluate the safety and effectiveness made by FT programs and MIS in combination or alone. Methods: We summarized an 11-year experience on gastric cancer patients undergoing elective laparotomy or minimally invasive gastric resection in standard cares (SC) or FT programs during January 2004 to December 2014. A total of 984 patients were enrolled and assigned into four groups: open gastrectomies (OG) with SC (OG + SC group, n = 167); OG with FT programs (OG + FT group, n = 277); laparoscopic gastrectomies (LG) with FT programs (LG + FT group, n = 248); and robot-assisted gastrectomies (RG) with FT programs (RG + FT group, n = 292). Patients’ data were collected to evaluate the clinical outcome. The primary end point was the length of postoperative hospital stay. Results: The OG + SC group showed the longest postoperative hospital stay (mean: 12.3 days, median: 11 days, interquartile range [IQR]: 6–16 days), while OG + FT, LG + FT, and RG + FT groups recovered faster (mean: 7.4, 6.4, and 6.6 days, median: 6, 6, and 6 days, IQR: 3–9, 4–8, and 3–9 days, respectively, all P < 0.001). The postoperative rehabilitation parameters such as flatus time after surgery (4.7 ± 0.9, 3.1 ± 0.8, 3.0 ± 0.9, and 3.1 ± 0.9 days) followed the same manner. After 30 postoperative days’ follow-up, the total incidence of complications was 9.6% in OG + SC group, 10.1% in OG + FT group, 8.1% in LG + FT group, and 10.3% in RG + FT group. The complications showed no significant differences between the four groups (all P > 0.05). Conclusions: ERAS protocols alone could significantly bring fast recovery after surgery regardless of the surgical technique. MIS further reduces postoperative hospital stay. It is safe and effective to apply ERAS protocols combined with MIS for gastric cancer.
Collapse
Affiliation(s)
- Xin-Xin Liu
- Department of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002; Department of Gastrointestinal Surgery, Northern Jiangsu People's Hospital, Clinical Medical School, Yangzhou University, Yangzhou, Jiangsu 225001, China
| | - Hua-Feng Pan
- Department of General Surgery, The First People's Hospital of Yangzhou, Clinical Medical School, Yangzhou University, Yangzhou, Jiangsu 225001, China
| | - Zhi-Wei Jiang
- Department of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, China
| | - Shu Zhang
- Department of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, China
| | - Zhi-Ming Wang
- Department of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, China
| | - Ping Chen
- Department of Gastrointestinal Surgery, Northern Jiangsu People's Hospital, Clinical Medical School, Yangzhou University, Yangzhou, Jiangsu 225001, China
| | - Yan Zhao
- Department of Gastrointestinal Surgery, Northern Jiangsu People's Hospital, Clinical Medical School, Yangzhou University, Yangzhou, Jiangsu 225001, China
| | - Gang Wang
- Department of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, China
| | - Kun Zhao
- Department of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, China
| | - Jie-Shou Li
- Department of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, China
| |
Collapse
|
34
|
Zhang S, Jiang ZW, Wang G, Feng XB, Liu J, Zhao J, Li JS. Robotic gastrectomy with transvaginal specimen extraction for female gastric cancer patients. World J Gastroenterol 2015; 21:13332-13338. [PMID: 26715817 PMCID: PMC4679766 DOI: 10.3748/wjg.v21.i47.13332] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2015] [Revised: 07/07/2015] [Accepted: 09/14/2015] [Indexed: 02/06/2023] Open
Abstract
AIM: To describe the application of complete robotic gastrectomy with transvaginal specimen extraction (TVSE) for gastric cancer patients.
METHODS: Between July and November 2014, eight female patients who were diagnosed with gastric adenocarcinoma underwent a TVSE following a full robot-sewn gastrectomy. According to the tumor location, the patients were allocated to two different groups; two patients received robotic total gastrectomy with TVSE and the other six received robotic distal gastrectomy with TVSE.
RESULTS: Surgical procedures were successfully performed in all eight cases without conversion. The mean age was 55.3 (range, 42-69) years, and the mean body mass index was 23.2 (range, 21.6-26.0) kg/m2. The mean total operative time and blood loss were 224 (range, 200-298) min and 62.5 (range, 50-150) mL, respectively. The mean postoperative hospital stay was 3.6 (range, 3-5) d. The mean number of lymph nodes resected was 23.6 (range, 17-27). None was readmitted within 30 d of postoperation. During the follow-up, no stricture developed nor was any anastomotic leakage detected.
CONCLUSION: It is possible to perform a TVSE following a full robot-sewn gastrectomy with standard D2 lymph node resection for female gastric cancer patients.
Collapse
|
35
|
Zhen SS, Li Y, Wang SM, Zhang XJ, Hao ZY, Chen Y, Wang D, Zhang YH, Zhang ZY, Ma JC, Zhou P, Zhang Z, Jiang ZW, Zhao YL, Wang XY. Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design. Emerg Microbes Infect 2015; 4:e64. [PMID: 26576341 PMCID: PMC4631931 DOI: 10.1038/emi.2015.64] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2015] [Revised: 09/01/2015] [Accepted: 09/09/2015] [Indexed: 12/19/2022]
Abstract
A universal rotavirus (RV) immunization program is a potentially cost-effective measure for preventing RV infection in China. However, the efficacy of the only licensed RV vaccine (Lanzhou lamb rotavirus vaccine, LLR), which is made by a domestic manufacturer, has not been proven by a properly designed clinical trial. In October 2011 to March 2012, to measure the potential protection provided by LLR, a case-control study nested in a population-based active diarrhea surveillance study of children <5 years of age was conducted in rural Zhengding county. During the study period, 308 episodes of diarrhea were identified as being caused by RV infection, resulting in an incidence rate of 48.0/1000 people/year. The predominant RV serotype was G3 (61.5%), followed by G1 (15.2%), and G9 (6.5%). Overall, a protection of 35.0% (95% confidence interval (CI), 13.0%-52.0%) was identified, and higher protection was found among moderate RV gastroenteritis cases caused by the serotype G3 (52.0% 95% CI: 2.0%-76.1%). A concurrently conducted case-control study comparing non-RV viral diarrheal cases with non-diarrheal controls in the same population found that the RV vaccine offered no protection against non-RV diarrhea. Even under a less ideal immunization schedule, the oral LLR conferred a certain level of protection against RV gastroenteritis. However, further studies are needed to understand the full characteristics of the LLR, including its efficacy when administered following the optimal regimen, the potential risk of inducing intussusception, and the direct and indirect protective effects of LLR.
Collapse
Affiliation(s)
- Shan-Shan Zhen
- Key Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University , Shanghai 200032, China
| | - Yue Li
- Key Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University , Shanghai 200032, China
| | - Song-Mei Wang
- Laboratory of Molecular Biology, Training Center of Medical Experiments, School of Basic Medical Sciences, Fudan University , Shanghai 200032, China
| | - Xin-Jiang Zhang
- Zhengding County Center for Disease Control and Prevention , Zhengding 050800, Hebei Province, China
| | - Zhi-Yong Hao
- Zhengding County Center for Disease Control and Prevention , Zhengding 050800, Hebei Province, China
| | - Ying Chen
- Key Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University , Shanghai 200032, China
| | - Dan Wang
- Key Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University , Shanghai 200032, China
| | - Yan-Hong Zhang
- Zhengding County Center for Disease Control and Prevention , Zhengding 050800, Hebei Province, China
| | - Zhi-Yong Zhang
- Zhengding County Center for Disease Control and Prevention , Zhengding 050800, Hebei Province, China
| | - Jing-Chen Ma
- Hebei Province Center for Disease Control and Prevention , Shijiazhuang 050800, Hebei Province, China
| | - Peng Zhou
- Key Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University , Shanghai 200032, China
| | - Zhen Zhang
- Key Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University , Shanghai 200032, China
| | - Zhi-Wei Jiang
- Department of Health Statistics, Fourth Military Medical University , Xi'an 710032, Shanxi Province, China
| | - Yu-Liang Zhao
- Hebei Province Center for Disease Control and Prevention , Shijiazhuang 050800, Hebei Province, China
| | - Xuan-Yi Wang
- Key Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University , Shanghai 200032, China
| |
Collapse
|
36
|
Desiderio J, Jiang ZW, Nguyen NT, Zhang S, Reim D, Alimoglu O, Azagra JS, Yu PW, Coburn NG, Qi F, Jackson PG, Zang L, Brower ST, Kurokawa Y, Facy O, Tsujimoto H, Coratti A, Annecchiarico M, Bazzocchi F, Avanzolini A, Gagniere J, Pezet D, Cianchi F, Badii B, Novotny A, Eren T, Leblebici M, Goergen M, Zhang B, Zhao YL, Liu T, Al-Refaie W, Ma J, Takiguchi S, Lequeu JB, Trastulli S, Parisi A. Robotic, laparoscopic and open surgery for gastric cancer compared on surgical, clinical and oncological outcomes: a multi-institutional chart review. A study protocol of the International study group on Minimally Invasive surgery for GASTRIc Cancer-IMIGASTRIC. BMJ Open 2015; 5:e008198. [PMID: 26482769 PMCID: PMC4611863 DOI: 10.1136/bmjopen-2015-008198] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
INTRODUCTION Gastric cancer represents a great challenge for healthcare providers and requires a multidisciplinary treatment approach in which surgery plays a major role. Minimally invasive surgery has been progressively developed, first with the advent of laparoscopy and recently with the spread of robotic surgery, but a number of issues are currently being debated, including the limitations in performing an effective extended lymph node dissection, the real advantages of robotic systems, the role of laparoscopy for Advanced Gastric Cancer, the reproducibility of a total intracorporeal technique and the oncological results achievable during long-term follow-up. METHODS AND ANALYSIS A multi-institutional international database will be established to evaluate the role of robotic, laparoscopic and open approaches in gastric cancer, comprising of information regarding surgical, clinical and oncological features. A chart review will be conducted to enter data of participants with gastric cancer, previously treated at the participating institutions. The database is the first of its kind, through an international electronic submission system and a HIPPA protected real time data repository from high volume gastric cancer centres. ETHICS AND DISSEMINATION This study is conducted in compliance with ethical principles originating from the Helsinki Declaration, within the guidelines of Good Clinical Practice and relevant laws/regulations. A multicentre study with a large number of patients will permit further investigation of the safety and efficacy as well as the long-term outcomes of robotic, laparoscopic and open approaches for the management of gastric cancer. TRIAL REGISTRATION NUMBER NCT02325453; Pre-results.
Collapse
Affiliation(s)
- Jacopo Desiderio
- Department of Digestive Surgery, St Mary's Hospital, University of Perugia, Terni, Italy
| | - Zhi-Wei Jiang
- Department of General Surgery, Jinling Hospital, Medical School, Nanjing University, Nanjing, China
| | - Ninh T Nguyen
- Department of Surgery, Division of Gastrointestinal Surgery, University of California, Irvine Medical Center, Orange, California, USA
| | - Shu Zhang
- Department of General Surgery, Jinling Hospital, Medical School, Nanjing University, Nanjing, China
| | - Daniel Reim
- Chirurgische Klinik und Poliklinik, Klinikum Rechts der Isar der Technischen Universität München, München, Germany
| | - Orhan Alimoglu
- Department of General Surgery, School of Medicine, Istanbul Medeniyet University, Istanbul, Turkey
| | - Juan-Santiago Azagra
- Unité des Maladies de l'Appareil Digestif et Endocrine (UMADE), Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg
| | - Pei-Wu Yu
- Department of General Surgery, Third Military Medical University Southwest Hospital, Chongqing, China
| | - Natalie G Coburn
- Division of General Surgery, Sunnybrook Health Sciences Centre, Toronto, Canada
| | - Feng Qi
- Department of Gastrointestinal Surgery, Tianjin Medical University General Hospital, Tianjin, China
| | - Patrick G Jackson
- Division of General Surgery, Medstar Georgetown University Hospital, Washington DC, USA
| | - Lu Zang
- Department of Surgery, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China
| | - Steven T Brower
- Department of Surgical Oncology and HPB Surgery, Englewood Hospital and Medical Center, Englewood, New Jersey, USA
| | - Yukinori Kurokawa
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Olivier Facy
- Service de chirurgie digestive et cancérologique CHU Bocage. Dijon, France
| | - Hironori Tsujimoto
- Department of Surgery, National Defense Medical College, Tokorozawa, Japan
| | - Andrea Coratti
- Division of Oncological and Robotic Surgery, Department of Oncology, Careggi University Hospital, Florence, Italy
| | - Mario Annecchiarico
- Division of Oncological and Robotic Surgery, Department of Oncology, Careggi University Hospital, Florence, Italy
| | - Francesca Bazzocchi
- Department of General Surgery, Division of General, Gastroenterologic and Minimally Invasive Surgery, GB Morgagni Hospital, Forlì, Italy
| | - Andrea Avanzolini
- Department of General Surgery, Division of General, Gastroenterologic and Minimally Invasive Surgery, GB Morgagni Hospital, Forlì, Italy
| | - Johan Gagniere
- Digestive and Hepatobiliary Surgery Department, University of Auvergne, University Hospital Estaing, Clermont-Ferrand, France
| | - Denis Pezet
- Digestive and Hepatobiliary Surgery Department, University of Auvergne, University Hospital Estaing, Clermont-Ferrand, France
| | - Fabio Cianchi
- Department of Surgery and Translational Medicine, Center of Oncological Minimally Invasive Surgery (COMIS), University of Florence, Florence, Italy
| | - Benedetta Badii
- Department of Surgery and Translational Medicine, Center of Oncological Minimally Invasive Surgery (COMIS), University of Florence, Florence, Italy
| | - Alexander Novotny
- Chirurgische Klinik und Poliklinik, Klinikum Rechts der Isar der Technischen Universität München, München, Germany
| | - Tunc Eren
- Department of General Surgery, School of Medicine, Istanbul Medeniyet University, Istanbul, Turkey
| | - Metin Leblebici
- Department of General Surgery, School of Medicine, Istanbul Medeniyet University, Istanbul, Turkey
| | - Martine Goergen
- Unité des Maladies de l'Appareil Digestif et Endocrine (UMADE), Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg
| | - Ben Zhang
- Department of General Surgery, Third Military Medical University Southwest Hospital, Chongqing, China
| | - Yong-Liang Zhao
- Department of General Surgery, Third Military Medical University Southwest Hospital, Chongqing, China
| | - Tong Liu
- Department of Gastrointestinal Surgery, Tianjin Medical University General Hospital, Tianjin, China
| | - Waddah Al-Refaie
- Division of General Surgery, Medstar Georgetown University Hospital, Washington DC, USA
| | - Junjun Ma
- Department of Surgery, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China
| | - Shuji Takiguchi
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
| | | | - Stefano Trastulli
- Department of Digestive Surgery, St Mary's Hospital, University of Perugia, Terni, Italy
| | - Amilcare Parisi
- Department of Digestive Surgery, St Mary's Hospital, University of Perugia, Terni, Italy
| |
Collapse
|
37
|
Liu HE, Wang HL, Jiang ZW, Zhu YQ, Wang K, Zhang GF, Tang LJ, Wang T. Effect of regulation of peritoneal lymphatic stomata on endotoxin induced lung injury in rats with early abdominal infection. Shijie Huaren Xiaohua Zazhi 2015; 23:2707-2713. [DOI: 10.11569/wcjd.v23.i17.2707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the effect of regulation of peritoneal lymphatic stomata on endotoxin induced lung injury in early abdominal infection.
METHODS: Fifty-four Wister rats were randomly divided into three groups: a control group (n = 18) to receive sham operation and intraperitoneal injection of saline solution, an experimental group (n = 18) to receive intraperitoneal ligation perforation (CLP) and cecum injection of saline solution, and an intervention group (n = 18) to receive CLP and intraperitoneal injection of losartan potassium 1.0 h before and 0.5 and 2.0 h after surgery. The aperture size and density of peritoneal lymphatic stomata, lymph endotoxin concentration, immunohistochemical average optical density of nuclear factor κB (NF-κB) P65 in lung tissue, and relative Caspase3 protease activity in lung tissue were measured and compared for the three groups.
RESULTS: As time went by, peritoneal lymphatic stomata aperture and density and lymph endotoxin concentration gradually increased in the experimental group (P < 0.05). In the intervention group, lymphatic stomata and endotoxin indexes were significantly higher after operation than before operation, and at 2.0 h after operation than at 0.5 h (P < 0.05). NF-κB P65 expression and Caspase3 activity in lung tissue were also significantly higher after operation than before operation, and at 2.0 h after operation than at 0.5 h (P < 0.05).
CONCLUSION: In early abdominal infection, angiotensin Ⅱ receptor (AngⅡ-R) inhibitor can regulate the peritoneal lymphatic stomata and reduce lung injury caused by endotoxin. Earlier intervention is associated with milder lung injury. s
Collapse
|
38
|
Jiang ZW, Liu J, Wang G, Zhao K, Zhang S, Li N, Li JS. Esophagojejunostomy reconstruction using a robot-sewing technique during totally robotic total gastrectomy for gastric cancer. Hepatogastroenterology 2015; 62:323-326. [PMID: 25916057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
BACKGROUND/AIMS The aim of this study was to report on the feasibility of esophagojejunostomy reconstruction using a robot-sewing technique during a completely robotic total gastrectomy for gastric cancer. METHODOLOGY Between May 2011 and July 2012, 65 patients in whom gastric adenocarcinoma was diagnosed underwent a completely robotic total gastrectomy, including a robot-sewing esophagojejunal anastomosis. We demonstrated the surgical techniques with analysis of clinicopathologic data and short-term surgical outcomes. RESULTS All robotic surgeries were successfully performed without conversion. Among the 65 patients, 46 were men and 19 were women. The mean age (± SD) was 57.8 ± 6.5 y. The mean total operative time (± SD), EJ anastomosis time (± SD), and blood loss (± SD) were 245 ± 53 min, 45 ± 26 min, and 75 ± 50 ml, respectively. The mean (± SD) post-operative hospital stay was 5.4 ± 2.5 d. One patient was readmitted for an intestinal obstruction and underwent re-operation 14 d post-operatively; he recovered uneventfully and was discharged 10 d post- operatively. During the follow-up, no patients developed an esophgojejunostomy stricture. CONCLUSIONS A robot-sewing anastomosis for esophagojejunostomy reconstruction during robotic total gastrectomy for gastric cancer is feasible. Indeed, a robot-sewing anastomosis for esophagojejunostomy reconstruction may become a standard surgical technique during completely robotic total gastrectomy for gastric cancer.
Collapse
|
39
|
Jiang ZW, Zhang S, Wang G, Zhao K, Liu J, Ning L, Li J. Single-incision laparoscopic distal gastrectomy for early gastric cancer through a homemade single port access device. Hepatogastroenterology 2015; 62:518-523. [PMID: 25916093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
BACKGROUND/AIMS We presented a series of single-incision laparoscopic distal gastrectomies for early gastric cancer patients through a type of homemade single port access device and some other conventional laparoscopic instruments. METHODOLOGY A single-incision laparoscopic distal gastrectomy with D1 + α lymph node dissection was performed on a 46 years old male patient who had an early gastric cancer. RESULTS This single port access device has facilitated the conventional laparoscopic instruments to accomplish the surgery and we made in only 6 minutes. Total operating time for this surgery was 240 minutes. During the operation, there were about 100 milliliters of blood loss, and 17 lymph-nodes were retrieved. CONCLUSION This homemade single port access device shows its superiority in economy and convenience for complex single-incision surgeries. Single-incision laparoscopic distal gastrectomy for early gastric cancer can be conducted by experienced laparoscopic surgeons. Fully take advantage of both SILS and fast track surgery plan can bring to successful surgeries with minimal postoperative pain, quicker mobilization, early recovery of intestinal function, and better cosmesis effect for the patients.
Collapse
|
40
|
Liu XX, Jiang ZW, Chen P, Zhao Y, Pan HF, Li JS. Full robot-assisted gastrectomy with intracorporeal robot-sewn anastomosis produces satisfying outcomes. World J Gastroenterol 2013; 19:6427-6437. [PMID: 24151361 PMCID: PMC3801313 DOI: 10.3748/wjg.v19.i38.6427] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/13/2013] [Revised: 08/07/2013] [Accepted: 08/20/2013] [Indexed: 02/06/2023] Open
Abstract
AIM: To evaluate the feasibility and safety of full robot-assisted gastrectomy with intracorporeal robot hand-sewn anastomosis in the treatment of gastric cancer.
METHODS: From September 2011 to March 2013, 110 consecutive patients with gastric cancer at the authors’ institution were enrolled for robotic gastrectomies. According to tumor location, total gastrectomy, distal or proximal subtotal gastrectomy with D2 lymphadenectomy was fully performed by the da Vinci Robotic Surgical System. All construction, including Roux-en-Y jejunal limb, esophagojejunal, gastroduodenal and gastrojejunal anastomoses were fully carried out by the intracorporeal robot-sewn method. At the end of surgery, the specimen was removed through a 3-4 cm incision at the umbilicus trocar point. The details of the surgical technique are well illustrated. The benefits in terms of surgical and oncologic outcomes are well documented, as well as the failure rate and postoperative complications.
RESULTS: From a total of 110 enrolled patients, radical gastrectomy could not be performed in 2 patients due to late stage disease; 1 patient was converted to laparotomy because of uncontrollable hemorrhage, and 1 obese patient was converted due to difficult exposure; 2 patients underwent extra-corporeal anastomosis by minilaparotomy to ensure adequate tumor margin. Robot-sewn anastomoses were successfully performed for 12 proximal, 38 distal and 54 total gastrectomies. The average surgical time was 272.52 ± 53.91 min and the average amount of bleeding was 80.78 ± 32.37 mL. The average number of harvested lymph nodes was 23.1 ± 5.3. All specimens showed adequate surgical margin. With regard to tumor staging, 26, 32 and 46 patients were staged as I, II and III, respectively. The average hospitalization time after surgery was 6.2 d. One patient experienced a duodenal stump anastomotic leak, which was mild and treated conservatively. One patient was readmitted for intra-abdominal infection and was treated conservatively. Jejunal afferent loop obstruction occurred in 1 patient, who underwent re-operation and recovered quickly.
CONCLUSION: This technique is feasible and can produce satisfying postoperative outcomes. It is also convenience and reliable for anastomoses in gastrectomy. Full robotic hand-sewn anastomosis may be a minimally invasive technique for gastrectomy surgery.
Collapse
|
41
|
Wang G, Jiang ZW, Zhao K, Gao Y, Liu FT, Pan HF, Li JS. Fast track rehabilitation programme enhances functional recovery after laparoscopic colonic resection. ACTA ACUST UNITED AC 2013; 59:2158-63. [PMID: 22366526 DOI: 10.5754/hge11957] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND/AIMS Fast track (IT) rehabilitation programmes have demonstrated advantages over traditional perioperative care after open colonic surgery; however. their contribution in recovery after laparoscopic colonic surgery is not clearly defined. This study was conducted to estimate the value of FT rehabilitation programme in laparoscopic colonic resections. METHODOLOGY This is a randomized prospective controlled clinical trial. Ninety-nine consecutive patients underwent elective laparoscopic colonic resection between February 2008 and March 2009. Forty-nine patients received FT multimodal rehabilitation programme as FT group and 50 patients underwent traditional perioperative care as non-FT group. Postoperative hospital stay, return of gastrointestinal function, postoperative complications were recorded. RESULTS Postoperative hospital stay was shorter in the FT group, a median duration of 4.0 days versus 5.0 days in the non-FT group (p<0.01). Gastrointestinal functional recovery occurred 1 day earlier in FT group (passage of flatus after 2.0 days vs. 3.0 days, p<0.01). There were no significant differences in complications within 30 postoperative days (12% in FT group vs. 20% in non-FT group, p=0.295). CONCLUSIONS When applied after laparoscopic colonic surgery, FT rehabilitation programme is feasible, safe and may lead to accelerated functional recovery and reductions in postoperative hospital stay.
Collapse
Affiliation(s)
- Gang Wang
- Research Institute of General Surgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, China
| | | | | | | | | | | | | |
Collapse
|
42
|
Jia HX, Yu L, Jiang ZW, Ji QH. Reply: Clarification of Data in the Recent Meta-analysis About Association Between IGF2BP2 rs4402960 Polymorphism and Risk of Type 2 Diabetes Mellitus. Arch Med Res 2012. [DOI: 10.1016/j.arcmed.2012.07.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
43
|
Su F, Zhang P, Jiang ZW, Peng DQ, Gao LY, Liu SQ, Qian LB, Ye ZG, Xia Q. [Expression and function of autophagy after ischemia/reperfusion in rats hippocampus neuron]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2011; 27:187-191. [PMID: 21845869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
OBJECTIVE To explore the expression of autophagy after ischemia/reperfusion and its possible function in rats hippocampus neurons. METHODS After 2 hours oxygen-glucose deprivation and different periods time of reperfusion (OGD/R) treatment in primary hippocampal neurons, neuron viability was evaluated by MTT assay, specific structure of autophagosome and specific protein of autophagy microtubule-associated protein 1 light chain 3 B (LC3B) were detected by transmission electron microscope and immunofluorescence respectively. The inhibitor of autophagy 3-Methyladenine (3-MA) was also used to exam the viability of neurons. RESULTS Treatment by OGD/R markedly reduced neuronal viability. Compared to the control group, autophagy existed in different time periods after OGD/R shown both in transmission electron microscope and immunofluorescence. Application of 3-MA significantly reduced neuronal viability. CONCLUSION Oxygen-glucose deprivation can activate autophagy in rat hippocampus neurons, which may resist the injury during ischemia/reperfusion.
Collapse
Affiliation(s)
- Fang Su
- Department of Physiology, Zhejiang University School of Medicine, Hangzhou 310058, China
| | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Bao Y, Jiang ZW, Xie LF, Liu FT, Li JS. [Robotic-assisted laparoscopic colectomy for colon cancer: a report of 13 cases]. Zhonghua Wei Chang Wai Ke Za Zhi 2011; 14:327-329. [PMID: 21614683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
OBJECTIVE To investigate the safety and feasibility of robotic-assisted laparoscopic colectomy for colonic cancer. METHODS The clinical outcomes of 13 patients with colon cancer undergoing robotic-assisted laparoscopic colectomy from May 2010 to November 2010 were retrospectively evaluated. RESULTS All the operations were performed successfully, including 5 right colectomies, 3 left colectomies, and 5 sigmoidectomies. The operative time was (171.5±31.8) minutes. The estimated blood loss was (54.6±21.8) ml. Time to the return of bowel function was (60.9±15.8) hours and postoperative hospital stay was (6.4±3.6) days. There was one patient developed fat liquefaction at the incision. No bleeding, anastomotic fistula, anastomotic stenosis, or other complications were found. CONCLUSION Robotic-assisted laparoscopic colectomy is safe and feasible for colon cancer resection.
Collapse
Affiliation(s)
- Yang Bao
- Research Institute of General Surgery, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China
| | | | | | | | | |
Collapse
|
45
|
Wang G, Jiang ZW, Xu J, Gong JF, Bao Y, Xie LF, Li JS. Fast-track rehabilitation program vs conventional care after colorectal resection: A randomized clinical trial. World J Gastroenterol 2011; 17:671-6. [PMID: 21350719 PMCID: PMC3040342 DOI: 10.3748/wjg.v17.i5.671] [Citation(s) in RCA: 67] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/11/2010] [Revised: 11/17/2010] [Accepted: 11/24/2010] [Indexed: 02/06/2023] Open
Abstract
AIM: To compare the fast-track rehabilitation program and conventional care for patients after resection of colorectal cancer.
METHODS: One hundred and six consecutive patients who underwent fast-track rehabilitation program were encouraged to have early oral feeding and movement for early discharge, while 104 consecutive patients underwent conventional care after resection of colorectal cancer. Their gastrointestinal functions, postoperative complications and hospital stay time were recorded.
RESULTS: The restoration time of gastrointestinal functions in the patients was significantly faster after fast-track rehabilitation program than after conventional care (2.1 d vs 3.2 d, P < 0.01). The percentage of patients who developed complications was significantly lower 30 d after fast-track rehabilitation program than after conventional care (13.2% vs 26.9%, P < 0.05). Also, the percentage of patients who had general complications was significantly lower 30 d after fast-track rehabilitation program than after conventional care (6.6% vs 15.4%, P < 0.05). The postoperative hospital stay time of the patients was shorter after fast-track rehabilitation program than after conventional care (5 d vs 7 d, P < 0.01). No significant difference was observed in the re-admission rate 30 d after fast-track rehabilitation program and conventional care (3.8% vs 8.7%).
CONCLUSION: The fast-track rehabilitation program can significantly decrease the complications and shorten the time of postoperative hospital stay of patients after resection colorectal cancer.
Collapse
|
46
|
Liu XX, Jiang ZW, Wang ZM, Li JS. Multimodal optimization of surgical care shows beneficial outcome in gastrectomy surgery. JPEN J Parenter Enteral Nutr 2010; 34:313-21. [PMID: 20467014 DOI: 10.1177/0148607110362583] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
BACKGROUND The aim of this trial was to compare multimodal optimization with conventional perioperative management in a consecutive series of patients undergoing gastrectomy procedures. METHODS According to randomized controlled studies and conclusions made by meta-analyses in colorectal surgery, optimized perioperative measures were designed and applied in gastrectomy surgery. Thirty-three patients were randomized to the optimized group and 30 patients to a control group. Two groups were treated in 1 center by a single surgical team in different wards. Both groups used patient-controlled intravenous analgesia for postoperative analgesia. The primary end point was length of postoperative hospital stay. Secondary outcomes included bowel function recovery after surgery, perioperative changes of inflammatory factors, glucocorticoid, insulin resistance, and body composition. Perioperative complications and adverse events were also recorded. RESULTS The groups were similar in terms of age, sex ratio, and Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM score). The optimized group was associated with a significantly shorter postoperative hospital stay compared with the conventional care group (P < .001). Durations of urinary catheterization and abdominal drainage were also less (P < .001). The diet program in the optimization group was well tolerated and was associated with an earlier recovery of gut function (P < .001). Proinflammatory factors were less elevated and body composition was more stable in the optimized group than in controls. There were no differences in morbidity or mortality between the groups. CONCLUSIONS Optimization of care in gastrectomy can shorten postoperative hospital stay and provides multiple beneficial outcomes, including hastening the return of gut function, without increasing morbidity.
Collapse
Affiliation(s)
- Xin-Xin Liu
- Department of General Surgery, Jinling Hospital, Nanjing University, Nanjing 210002, Jiangsu Province, China
| | | | | | | |
Collapse
|
47
|
Zhu XG, Tao L, Mei ZR, Wu HP, Jiang ZW. Aspisol inhibits tumor growth and induces apoptosis in breast cancer. Exp Oncol 2008; 30:289-294. [PMID: 19112426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
UNLABELLED Nonsteroidal anti-inflammatory drugs inhibit cell proliferation and induce apoptosis in various cancer cell lines, which is considered to be an important mechanism for their anti-tumor activity and cancer prevention. However, the molecular mechanisms through which these compounds induce apoptosis are not well understood. AIM to determine the effects of nonselective cyclooxygenase-2 (COX-2) inhibitor, aspisol on breast cancer cells in vitro and in vivo. METHODS The cytotoxic activity of aspisol was evaluated by MTT assay. The apoptosis index of cells was measured by flow cytometry. Immunohistochemical staining was used to detect expressions of COX-2 and caspase-3 in MDA-MB-231 cells. The expression of bcl-2 and bax was analyzed by Western blot analysis. The content of prostaglandin E2 (PGE2) in MDA-MB-231 cells was estimated by ELISA. In vivo apoptosis of the tumor cells was detected by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL). RESULTS Our results showed that aspisol reduced viability of MDA-MB-231 cells in time- and dose- dependent fashions and induced apoptosis by increase of caspase-3 and bax expressions while decrease of COX-2 and bcl-2 expression in vitro. In addition, exposure to aspisol decreased the basal release of PGE2. In vivo, aspisol also inhibited the proliferation of breast cancer cells and induced their apoptosis. CONCLUSIONS Our in vitro and in vivo data indicated that the antitumor effects of aspisol on breast cancer cells was probably mediated by the induction of apoptosis, and it could be linked to the downregulation of the COX-2 or bcl-2 expression and up-regulation of caspase-3 or bax expression.
Collapse
Affiliation(s)
- X G Zhu
- Department of Pharmacology, Pharmacy Department, Bengbu Medical College, Bengbu 233003, China
| | | | | | | | | |
Collapse
|
48
|
Abstract
AIM: To investigate the feasibility of compression anastomosis clip (CAC) for gastrointestinal anastomosis proximal to the ileocecal junction.
METHODS: Sixty-six patients undergoing gastrointe-stinal anastomosis proximal to the ileocecal junction were randomized into two groups according to the anastomotic method, CAC or stapler.
RESULTS: The postoperative recovery of patients in CAC and stapled anastomosis groups was similar. No postoperative complication related to the anastomotic method was found in either group. Both upper gastrointestinal contrast radiography at the early postoperative course and endoscopic examination after a 6-mo follow-up showed a better healing at the compression anastomosis.
CONCLUSION: CAC can be used not only in colonic surgery but also in gastrointestinal anastomosis. Our result strongly suggests that CAC anastomosis is safe in various complication circumstances. However, it should be further confirmed with a larger patient sample.
Collapse
|
49
|
Wang ZM, Jiang ZW, Diao YQ, Wu SM, Ding K, Li N, Li JS. [Clinical application of percutaneous endoscopic gastrostomy/jejunostomy]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2008; 30:249-252. [PMID: 18686599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
OBJECTIVE To summarize the clinical experiences in percutaneous endoscopic gastrostomy (PEG)/percutaneous endoscopic jejunostomy (PEJ). METHODS We retrospectively analyzed the clinical data of 578 patients who received either PEG or PEJ from July 2001 to December 2007 in our hospital. The data analyzed included the type, aim, duration, success rate, and complications of these procedures. RESULTS Of 578 patients, 247 patients underwent PEG, 293 patients underwent percutaneous endoscopic gastrojejunostomy (PEGJ), 4 patients received percutaneous endoscopic duodenostomy (PED), 4 patients underwent direct percutaneous endoscopic jejunostomy (DPEJ), 4 patients underwent percutaneous endoscopic colostomy (PEC), and 26 patients received PEG/J combined stents. These procedures were performed in different clinical conditions, including enteral nutrition (n = 329), decompression combined enteral nutrition (n = 133), decompression of the gastrointestinal tract (n = 103), enteral nutrition combined bile refeeding (n = 5), perioperative applications (n = 4), and coloclysis (n = 4). Tubes were successfully placed in 578 patients (98.0%) in an average time of (7.5 +/- 1.9) min in PEG, (17.7 +/- 4.2) min in PEGJ, (14.8 +/- 2.1) min in DPEJ, (12.3 +/- 2.5) min in PED, (11.3 +/- 2.6) min in PEC, and (30.2 +/- 5.2) min in PEG/J combined stent, respectively. No procedure-related complications were observed. Major complications were found in 6 patients (1.04%) and minor complications in 36 patients (6.23%). The duration of tube functioning was (168.37 +/- 198.64) d. CONCLUSIONS PEG/PEJ are easy to handle, effective, safe, and convenient for nursing. The endoscopic method of tube placement can be performed at the bedside and allow for enteral feeding, gastrointestinal decompression, and internal biliary drainage to be rapidly and efficiently achieved.
Collapse
Affiliation(s)
- Zhi-Ming Wang
- Research Institute of General Surgery, Nanjing General Hospital of PLA, Nanjing Military Command, Nanjing 210002, China.
| | | | | | | | | | | | | |
Collapse
|
50
|
Li N, Zhu WM, Ren JA, Li YS, Li M, Jiang ZW, Li JS. [Management of chronic radiation enteritis with intestinal obstruction]. Zhonghua Wei Chang Wai Ke Za Zhi 2007; 10:515-517. [PMID: 18000768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
OBJECTIVE To explore the therapeutic method and efficiency of chronic radiation enteritis with intestinal obstruction. METHODS Clinical data of 51 patients of chronic radiation enteritis with intestinal obstruction from Aug. 2001 to Dec. 2006 were analyzed retrospectively. RESULTS The mean time from the ending of radiation to the occurrence of obstruction was (11.9 +/- 22.6) months. Conservative treatment, intestinal resection-anastomosis, enterostomy, bypass operation and enterolysis were applied and performed in above 51 cases. Two patients could not receive operation because of wild metastasis. One died of peritoneal bleeding after operation. Forty-eight cases were cured and the curative rate was 94.1%. CONCLUSION Therapeutic regimen should be chosen according to nutritional status and intestinal impairment in chronic radiation enteritis with intestinal obstruction.
Collapse
Affiliation(s)
- Ning Li
- Department of General Surgery, Jinling Hospital, Nanjing University of Medical School, Nanjing, China.
| | | | | | | | | | | | | |
Collapse
|